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Cellular metabolism plays a critical role in human health and homeostasis and is implicated in a 
large number of pathological conditions. While clinical imaging tools have emerged to probe 
metabolism at the tissue and organ level, the tools to probe metabolic dynamics at the cellular level 
have been slow to develop. This thesis represents a step toward realizing one such tool through the 
use of two-photon fluorescence lifetime imaging microscopy (2P-FLIM) of reduced nicotinamide 
adenine dinucleotide (NADH). This autofluorescent co-enzyme is involved in both aerobic and 
anaerobic metabolic processes which can be differentiated utilizing this advanced imaging 
approach. This thesis first presents a study of cell death dynamics in vivo, with cellular resolution, 
with a custom-built microscope utilizing a commercial 2P-FLIM detection system. Motivated by 
the limitations of this study in observing the early dynamics, a high-speed 2P-FLIM instrument is 
developed and characterized. This developed system is then directly applied to study the rapid, 
transient metabolic dynamics of cell death, providing new insight into this dynamic metabolic 
environment. Finally, this tool is combined with fluorescence calcium imaging to study the 
metabolic dynamics in neuronal activation, revealing a strong cell-specific response to brain 
activity in dissociated hippocampal cultures. These studies together demonstrate the potential of 
dynamic metabolic imaging as a tool for both basic scientific research and potential clinical 
translation. Through further development of these imaging approaches, the complex relationship 
between cellular metabolism and human health and disease can be further disentangled, providing 
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1.1 Optical microscopy 
First used for biological imaging in the 17th century, the optical microscope has become 
commonplace in any basic science or medical laboratory setting. While more advanced 
microscopy techniques have been developed over the years, the nondestructive nature of optical 
imaging as well as the ability to achieve resolution on the order of nanometer scales has provided 
a significant advantage and has enabled scientists and clinicians to study life at the cellular and 
even subcellular level. Although the field is hundreds of years old, microscopy is still a remarkably 
active field of research, and recent breakthroughs including the 2014 Nobel-prize winning work 
in super-resolution microscopy [1-3] further demonstrate the fact that new discoveries and 
technological improvements occur frequently. 
Multiphoton microscopy (MPM), in particular, is a powerful set of nonlinear optical microscopy 
techniques that has several advantages over more traditional optical imaging techniques [4]. 
Specifically, MPM techniques can typically image hundreds of microns into dense, highly 
scattering tissue with limited photobleaching or toxicity compared to traditional optical 
microscopes. In addition to this, functional imaging with MPM based on intrinsic optical contrast 
can provide specific, physiological information regarding specimens without the need for dyes or 
labels. This thesis will focus on the development of one such MPM technique known as two-
photon fluorescence lifetime imaging microscopy (2P-FLIM), based on the principles of two-
photon fluorescence (2PF), for the purpose of imaging dynamic changes in metabolism in living 
cells and tissues. By optically probing the metabolism, or energy production capabilities of living 
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cells, cellular function and potential dysfunction can be identified and studied at the cellular and 
potentially subcellular level. 
1.2 Metabolic imaging and applications to cell death and neuroscience 
The field of metabolic imaging has a rich history tied directly to clinical imaging, based on 
techniques such as positron emission tomography (PET) and magnetic resonance spectroscopy 
(MRSI) [5]. By utilizing specific metabolic probes such as [18F]fluoro-deoxyglucose ([18F]FDG), 
in the case of PET, or performing spectroscopic analysis with proton imaging in the case of MRSI, 
the metabolic state of tissue can be analyzed noninvasively in vivo with high sensitivity. These 
methods have been shown effective in a wide range of clinical settings such as cancer imaging [6, 
7] and brain metabolism imaging [8]. Due to the rich information provided, these imaging 
modalities have become essential in clinical functional imaging. In fact, [18F]FDG has been widely 
used in clinical oncology for many years and is a powerful tool in the diagnostic and prognostic 
assessment of cancers [9]. 
Borrowing from many of these ideas, many optical approaches to functional metabolic imaging 
have been successfully developed in recent years. While these techniques are not capable of 
providing the same whole-body scale imaging of traditional clinical imaging, the biggest 
advantage of optical imaging is the increased spatial resolution, on the order of hundreds of 
nanometers, approximately 1,000-10,000 times better than clinical techniques like magnetic 
resonance imaging (MRI) as shown in Figure 1.1, permitting high-sensitivity visualization of 
metabolism at the single-cell level [10]. Of the many contrast sources available for optical 
metabolic imaging, the use of 2P-FLIM imaging of the endogenous metabolic coenzymes reduced 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD) present many 
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desirable properties. First demonstrated in the early 1990s, the temporal properties of NADH 
autofluorescence are highly distinguishable under conditions of aerobic and anaerobic metabolism 
[11]. Thus, intracellular imaging of NADH has become a widely utilized tool to probe energy 
production processes at the single-cell level in vivo without the use of any exogenous probes or 
ionizing radiation. 
 
Figure 1.1 Imaging depth and spatial resolution of various imaging modalities. Optical microscopy methods, as shown 
in the bottom left corner of the diagram, are capable of cellular resolution imaging with high molecular sensitivity. 
Figure used with permission from [12]. 
1.3 Limitations and current challenges in optical metabolic imaging 
While 2P-FLIM of NADH has been widely used to study cellular metabolism at the cellular level 
and has shown promise for studying in vivo cancer progression [13], therapeutic efficacy 
monitoring in vitro [14], and clinical skin imaging [15], limitations to the technology and 
approaches currently utilized present severe challenges to the pursuit of studying metabolic 
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dynamics at the single-cell level. Several of these challenges and the proposed strategies for 
overcoming them are addressed below. 
1.3.1 In vivo imaging of cell death dynamics 
Previously, 2P-FLIM of NADH has been demonstrated to be a sensitive biomarker of 
mitochondrial apoptosis induced by a variety of chemical compounds [16]. While this has been 
assessed in vitro in both cell [17] and engineered tissue cultures [18], the translation of this 
approach to an in vivo microenvironment remains to be shown. This is of critical importance in 
validating in vitro biomarkers and identifying deviations from imaging results observed in 
previous studies that may be related to the differences between the in vivo and in vitro metabolic 
microenvironments, such as the presence of a functional vascular system and the availability of 
critical nutrients [19].  
1.3.2 Speed limitations in traditional 2P-FLIM imaging 
Another critical technical limitation of currently utilized 2P-FLIM approaches is the inherently 
slow speed of commercially available systems. Several studies report pixel dwell times on the 
order of tens or hundreds of microseconds, which can lead to long acquisition times up to 10 
minutes to acquire a single frame with acceptable resolution and field-of-view (FOV) [17]. While 
these systems are capable of obtaining high-quality measurements of single-photon events with 
extremely high temporal resolution (on the order of picoseconds), this comes overwhelmingly at 
the expense of imaging speed, fundamentally limiting the study of transient metabolic dynamics 
such as those in the early stages of apoptosis induction [20] as well as in studying the metabolic 
dynamics of brain activation [21].  
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1.3.3 Tracking of metabolic transient dynamics during cell death induction 
While 2P-FLIM has been shown to be a powerful tool for the study of cell death, the speed 
limitations discussed above in traditional commercial systems have limited the study of the 
transient metabolic dynamics observed, particularly in compounds known to rapidly induce 
apoptosis, such as staurosporine (STS) [22]. Previous metabolic 2P-FLIM studies of STS-induced 
apoptosis have indeed revealed extremely rapid metabolic dynamics that could not be fully 
resolved due to the slow imaging speed of traditional 2P-FLIM platforms [17, 18].  
1.3.4 Tracking of metabolic transient dynamics during neural activity 
While the human brain only accounts for approximately 2% of body weight, it consumes 20% of 
the energy supply of the body [23]. Interestingly, the cellular basis of this massive energy burden 
remains an important open question in neuroscience [24]. Of particular interest is the debate 
surrounding the metabolic role of astrocytes, a supporting glial cell in the brain. Evidence has been 
provided both supporting and rejecting the hypothesis that astrocytes rapidly undergo anaerobic 
metabolism to generate and shuttle lactate to neurons, which can use this lactate as a substrate for 
efficient aerobic metabolism [25]. While this hypothesis has been explored in a large number of 
studies, it remains controversial because previous metabolic imaging studies utilizing NADH have 
been limited by spatial resolution, specificity of aerobic vs. anaerobic metabolism, and imaging 
speed [26].  
1.4 Overview of the thesis 
Through the development of new technology and imaging approaches, this thesis aims to address 
these critical problems in tracking and imaging cellular metabolic dynamics and provide advanced 
tools for further exploring these dynamics across a variety of fields. Chapter 2 of this thesis 
provides background information critical to the developments of this thesis. Chapter 3 describes 
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the development of a 2P-FLIM experimental approach to study the in vivo dynamics associated 
with apoptosis induction in a mouse model. Chapter 4 presents a novel high-speed 2P-FLIM 
imaging platform capable of imaging metabolic dynamics at 20 frames per second (FPS), several 
orders of magnitude faster than currently utilized metabolic 2P-FLIM imaging systems. Chapter 5 
describes an imaging approach based on the high-speed 2P-FLIM system developed in Chapter 4 
to study the rapid dynamics observed to occur within seconds following the addition of apoptosis-
inducing compounds. Chapter 6 proposes a multimodal fluorescence imaging strategy combining 
high-speed 2P-FLIM imaging of NADH and 2PF imaging of calcium dynamics in vitro to better 
study the cellular basis of energy production during neural activation. Finally, Chapter 7 presents 
a brief summary of the work here as well as a survey of continuing work that may be pursued to 




2  BACKGROUND 
2.1 Nonlinear optical microscopy 
The field of nonlinear optics arose soon after the invention of the laser. This intense, coherent light 
source provided the necessary tool to practically and efficiently generate nonlinear light-matter 
interactions. These nonlinear optical interactions, forming the basis for contrast in nonlinear 
optical microscopy, physically arise from the discovery that a strong optical field will impart a 
nonlinear polarization on the material. This interaction is typically modeled as a power series 
expansion of the field as shown in Eqn. (2.1), 
 
( ) ( ) ( )( )1 2 32 30 ...E EP E  + + += ,  (2.1) 
where 0  is the permittivity of free space, 
( )n  are the linear and nonlinear susceptibilities of the 
material, and E is the electric field of the incident light. As the field of nonlinear optics matured, 
the idea of utilizing these interactions as contrast mechanisms for imaging shortly followed for a 
variety of applications in diverse fields such as biomedicine and materials science. Today, 
nonlinear optical imaging encompasses a variety of such imaging techniques often employed 
together simultaneously in a multimodal platform utilizing a single laser source [27]. Some 
common modalities include two- and three-photon fluorescence (2PF and 3PF) microscopy [28, 
29], second and third harmonic generation (SHG and THG) microscopy [30, 31], and nonlinear 
Raman-based modalities such as coherent anti-stokes Raman scattering (CARS) microscopy [32] 
and stimulated Raman scattering (SRS) microscopy [33]. These nonlinear microscopy techniques 
have several advantages over traditional confocal microscopy imaging approaches including 
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enhanced imaging depth, chemically and molecularly sensitive label-free contrast, and greatly 
reduced photobleaching effects, each of which is discussed in further detail below. 
2.1.1 Imaging depth 
To begin, imaging depth in scattering media is dependent on two critical parameters: optical 
scattering and absorption. In the case of light microscopy, Rayleigh scattering becomes the 
dominant effect at lower wavelengths due to a λ-4 dependency, while at longer wavelengths in the 
infrared, water absorption becomes the main contribution of optical attenuation in tissue as can be 
seen in Figure 2.1. Nonlinear microscopy benefits from the fact that excitation is provided by near-
infrared (NIR) laser sources where attenuation due to these effects is minimized allowing deeper 
imaging compared to traditional confocal microscopy utilizing visible light in the 300-600 nm 
range, which is severely affected by increased scattering at these shorter wavelengths [34].  
 
Figure 2.1 Absorption spectra for relevant biological compounds. Figure adapted with permission from [35]. 
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2.1.2 Molecular sensitivity 
Additionally, these techniques show advantages due to their inherent molecular sensitivity. This 
property of nonlinear microscopy is modality-specific but permits highly specific imaging contrast 
to be obtained. For example, while confocal autofluorescence microscopy with excitation provided 
with visible or ultraviolet light may excite a large number of endogenous fluorophores in tissue 
(Figure 2.2), the generated fluorescence signal from 2PF microscopy with excitation provided at 
720-750 nm pulsed lasers will be dominated by the endogenous metabolic co-enzyme NADH [36], 
providing specific metabolic contrast difficult to isolate with label-free confocal microscopy. 
Similarly, SHG imaging of biological tissues is primarily associated with collagen due to the 
unique non-centrosymmetric crystal structure of this structure necessary to generate such a signal, 
and SRS imaging can be tuned to probe specific molecular vibrational states providing image 
contrast with chemical specificity. 
 





2.1.3 Photobleaching and photodamage 
Finally, due to the nonlinear interactions between the specimen and the excitation, photobleaching 
and other undesirable light-matter interactions away from focus are minimized as shown in Figure 
2.3. In confocal microscopy (Figure 2.3a), the excitation beam excites fluorophores at nearly all 
depths, due to the high linear absorption cross-sections of most fluorophores. However, Figure 
2.3b shows the results for 2PF microscopy where NIR excitation light is utilized. Here, 
fluorescence emission is only generated at the focal plane of the microscope. This is due to the 
much weaker nonlinear absorption cross-sections, which require pulsed lasers and comparably 
high incident light intensity to generate a significant nonlinear signal. This greatly minimizes 
nonlinear interactions away from focus, reducing potential photobleaching and damage effects. 
 
Figure 2.3 Comparison of traditional confocal and two-photon fluorescence microscopy. (a) In confocal fluorescence 
microscopy, a large volume of the sample is excited by the incident light and a pinhole must be used to reject the light 
away from the focus. (b) In two-photon fluorescence microscopy, signal generation is restricted to focus of the 
objective lens providing intrinsic depth sectioning and reduced photobleaching and damage. Figure adapted with 
permission from [4]. 
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2.2 Two-photon fluorescence microscopy 
2PF microscopy is a powerful imaging modality based on the nonlinear optical absorption of 
fluorescent molecules. Physically, the nonlinear excitation process can be modeled as a third-order 
nonlinear optical process. First, consider a monochromatic optical field of the form 
 ( )  exp . .E t A j t c c= − + ., (2.2) 
where A is the field amplitude,   is the angular frequency of the wave and c.c. represents the 
complex conjugate of the previous term. Inserting this expression for the electric field in Eqn. (2.1) 
and considering only the first- and third-order nonlinear responses of the material polarization 
oscillating at angular frequency  , the following terms arise: 
 ( )  2(1) (3)0 expP E A j t   = + − . (2.3) 
This interaction is interesting as it has the net effect of changing the effective medium properties 
based on the applied optical field. The nonlinear contribution of Eqn. (2.3) is known as the Kerr 
effect, which can be described as an optical intensity-dependent index of refraction. As the 
imaginary part of the susceptibility, which is proportional to the refractive index, is related to 
optical absorption, the Kerr effect in Eqn. (2.3) gives rise to a nonlinear absorption term dependent 
on the intensity of the field. Typically after the nonlinear absorption and a thermal relaxation 
process into a slightly lower energy state, the molecule will return to the ground state, emitting a 
fluorescence photon of energy equal to the transition energy between these states, as can be seen 




Figure 2.4 Jablonski diagram demonstrating the nonlinear process of two-photon absorption and fluorescence. 2PF 
requires the simultaneous absorption of two photons to excite a molecule from the ground state to the excited state. A 
fluorescence photon is then emitted as the molecule returns to the ground state after a stochastic time delay. 
As has been discussed above, 2PF has many advantages over traditional confocal fluorescence 
microscopy techniques including deeper imaging penetration and reduced photobleaching due to 
a confined excitation volume [35]. Contrast in 2PF can arise from a variety of fluorescent sources 
from endogenous biomolecules to exogenous fluorescent labels and dyes. 
Spatial resolution in 2PF microscopy is governed primarily by diffraction theory. In the lateral 






= , (2.4) 
where d is the diffraction-limited spot size, λ is the wavelength of light, and NA is the numerical 
aperture of the objective [38]. Generally, the numerical aperture of most 2PF microscopes is 
between 1.0 and 1.3, providing lateral resolution of 200-500 nm. Similarly, the axial resolution of 











= ,  (2.5) 
where n is the index of refraction of the medium. Again, assuming a numerical aperture of 1.0, it 
is noteworthy that the axial resolution of a confocal microscope is several times worse than the 
lateral resolution. However, it is important to note that the nonlinear interactions of 2PF are not 
considered in these equations, which are based on a general confocal microscope architecture. 
While the excitation spot of a 2PF microscope will typically be larger than that of a fluorescence 
confocal microscope, the emission spot will be much smaller due to the weak nonlinear processes. 
Thus, the resolution of 2PF microscopy is generally considered to be comparable to that of 
confocal microscopy in most circumstances. 
2.3 Two-photon fluorescence lifetime imaging microscopy (2P-FLIM) 
An important extension to 2PF microscopy is an imaging modality known as fluorescence lifetime 
imaging microscopy (FLIM) [39]. In FLIM, the excited state lifetime of a fluorophore provides 
the image contrast rather than the emission intensity, as is typically probed in 2PF microscopy. 
The temporal emission of the 2PF process is based on the spontaneous decay rates from the excited 
states of fluorophores of interest. The fluorescence emission is therefore incoherent, and the release 
of photons is stochastically governed by these population dynamics resulting in an observed 
exponential intensity decay for a single fluorophore given by 








where 0I  is the initial intensity and   is the lifetime, a parameter dependent on the fluorophore as 
well as the microenvironment of the fluorophore. More generally, assuming an environment with 
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multiple fluorophores, the measured temporal dynamics of fluorescence can be modeled as a 













 , (2.7) 
where 
iA  represents the relative amplitudes of the fluorescence decay from each fluorophore and 
the i  are the lifetimes of each fluorophore. In this context, FLIM has proven useful  as a tool for 
unmixing fluorescence signals with highly overlapping emission spectra, but drastically different 
lifetimes [40], as well as for studying dynamic sample environment changes such as pH [41] and 
local oxygen and calcium concentrations [42, 43]. 
The fluorescence lifetime of a fluorophore can be measured in either the time or frequency domain, 
each of which has its own advantages and disadvantages. The first FLIM platform was developed 
for the frequency domain [39]. As seen in Figure 2.5, the technique is implemented using an 
intensity modulated excitation source with detector modulated at this same frequency. When 
exciting a fluorescent sample with a periodic signal, the result is a time-delayed, scaled copy, 
where the time-delay is related to the lifetime decay of the fluorophore. Images are recorded at 
various phase delays of the modulated image intensifier in order to recover this time delay and 
extract the lifetime at each pixel. This approach has found general use in many high-speed systems 
but is not typically used for 2P-FLIM due to the typically low count rates generated by the weak 




Figure 2.5 Principle of operation for frequency-domain FLIM measurements. Frequency modulated excitation light 
is used to generate a time-delayed fluorescence emission, which can be used to recover the fluorescence lifetime 
through the recovery of the phase delay between the laser excitation and fluorescence emission. 
Instead, most 2P-FLIM systems rely on time-domain approaches that utilize a pulsed laser to 
record the time decay of fluorescence as shown in Figure 2.6 [44]. This method presents a more 
direct measurement of the fluorescence lifetime, and through the utilization of high-speed 
sampling techniques, fluorescence decay measurements can be made in the time-domain at 
picosecond resolutions, allowing determination of fluorescence lifetime with high-precision at 
low-signal levels. However, as will be discussed later in this chapter, this typically comes at the 
expense of imaging speed, preventing the study of dynamic microenvironments. 
Of interest in this thesis is the application of 2P-FLIM to metabolic imaging. Through imaging 
endogenous NADH or FAD as was mentioned in Chapter 1, 2P-FLIM can be used to determine 
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the free and protein-bound intracellular concentrations of these endogenous molecules, which are 
strong measures of cellular metabolic activity [11]. 
 
Figure 2.6 Principle of operation for time-domain FLIM measurements. Short laser pulses are used to excite 
fluorophores to an excited state and the output fluoresce emission is measured with high temporal resolution. 
2.4 Fluorescence-based metabolic imaging 
Fluorescence has long been used to as a tool to study metabolic interactions in living cells, dating 
back to the 1950s with the pioneering work of Britton Chance [45]. The discovery that metabolic 
state is directly linked to the fluorescence properties of endogenous NADH and FAD has led to 
the development of optical methods that can probe cellular energy production without the use of 
dyes or labels. With the development of modern nonlinear microscopy, 2PF microscopy and 2P-
FLIM have been shown to be capable of deep imaging with subcellular resolution to probe 
metabolism both in vitro and in vivo. This has shown promise for many applications such as in 
vivo imaging of cancer progression [13] and tracking the in vivo skin response to topical steroid 
treatment [46]. 
As has been previously discussed, 2P-FLIM imaging of NADH potentially presents the most 
sensitive label-free tool for probing cellular metabolism. NADH is involved in several metabolic 
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pathways but is of central importance in oxidative phosphorylation and glycolysis, which 
respectively represent two key aerobic and anaerobic metabolic processes to generate energy 
stored in adenosine triphosphate (ATP) in the cell. While glycolysis occurs in the cytoplasm of the 
cell and involves reduction of the cell’s pool of free NAD+ to produce unbound NADH, oxidative 
phosphorylation requires binding of the NADH to complex I in mitochondria, causing an increase 
in the quantum yield, changes to the emission spectrum, and an increase in the excited state lifetime 
of NADH compared to the unbound state as shown in Figure 2.7 [47].  
 
Figure 2.7 Pictorial description of fluorescent metabolic coenzymes and processes in the cell. Free NADH in the 
cytoplasm is involved in the aerobic glycolysis process while NADH bound to the mitochondria is involved in the 
aerobic oxidative phosphorylation process. 
While spectral analysis of NADH fluorescence had been the standard technique for metabolic 
profiling, fluorescence lifetime imaging of NADH was first shown in 1992 [11]. Notably, it was 
shown that while free and protein-bound NADH have subtle spectral differences, the excited state 
lifetimes of these molecules are quite distinct, with free NADH having a lifetime of approximately 
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0.4 ns while protein-bound NADH can take on a large range of values from 1.4 ns to 9 ns depending 
on environmental factors [47]. 
Recently, the implementation of 2P-FLIM for metabolic imaging of NADH has become a powerful 
approach for metabolic imaging, and commercial products to implement lifetime imaging into a 
standard 2PF system are available from several companies such as Becker-Hickl and PicoQuant. 
In these systems, the obtained lifetime decay curves at each pixel are modeled as a biexponential 
decay to account for the free and bound states of NADH given by 




I t A A
 
   
= − + −   
   
 , (2.8) 
where the iA  are the relative amplitude contributions of free and protein bound NADH and the i  
are the free and bound lifetimes. Typically, these parameters are combined into a single metric 













.  (2.9) 
This metric is then used to create a colormap that is applied to the 2PF intensity image acquired as 
shown in Figure 2.8. In these images, which will be presented throughout this thesis, redder hues 
correspond to regions of relatively increased glycolysis while bluer hues correspond to regions of 
relatively increased oxidative phosphorylation. 
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2.5 Instrumentation and data analysis for 2PF and 2P-FLIM imaging 
The typical, generic system design for a 2PF system is shown in Figure 2.9. These systems consist 
of an ultrafast laser source, excitation optics including the beam scanning system and microscope 
objective, detection optics and electronics, and data acquisition PC. Tailoring of each of these 
components to the application at hand is important when making practical decisions about system 
development. Each of these components is discussed below in the context of dynamic 2PF and 2P-
FLIM imaging of NADH as discussed above. 
  
Figure 2.8 Color-coded FLIM image of human skin keratinocytes. Redder hues correspond to regions of more 
glycolysis while bluer hues correspond to regions of more oxidative phosphorylation.  
2.5.1 Laser source 
To begin, the most crucial element of any nonlinear multiphoton microscope is the laser source. 
In order to efficiently excite molecules through the relatively weak two-photon absorption 
pathway, the density of photons at the sample must be extremely high. In order to accomplish this, 
ultrafast laser sources capable of emitting femtosecond pulses of NIR light are utilized, the most 
common of which in 2PF imaging is the Ti:sapphire laser [48]. This source is particularly powerful 
due to its commercial availability, ultrashort pulse duration, tunability across a large spectral band 
in the NIR range, and high emission power. For imaging of NADH dynamics, these parameters 
 20 
  
are of crucial importance. To most efficiently excite this molecule, ultrashort pulses at 700-750 
nm are typically utilized, which can be provided by most tunable Ti:sapphire lasers. 
 
Figure 2.9 General system diagram for a generic 2PF microscope. A general 2PF microscope consists of a laser 
excitation source, excitation optics, detection optics and electronics, and data acquisition and processing systems. 
2.5.2 Excitation and detection optics 
Next, the excitation optics must be designed to raster scan a sharply focused point of light across 
the sample, controlled by the scanning optics and objective of the system. In the majority of 2PF 
and 2P-FLIM microscopes, two mechanical galvanometric (galvo) scanning mirrors are utilized 
with a 1:1 lens relay system separating the mirrors in order to scan a large FOV at the sample. 
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Additionally, the objective chosen plays a critical role in microscope performance. Ideally, a high 
NA, low magnification objective lens is desired for point scanning microscopy approaches. The 
high NA (typically greater than 1.0) is necessary as this parameter is directly related to the size of 
the diffraction limited focus of the beam. Additionally, at a high NA, the density of photons is 
larger and will elicit a stronger nonlinear interaction with the sample. The magnification of the 
objective has the effect of determining the extent of the scan range at the sample. Low 
magnification is ideal for point-scanning approaches as this allows imaging across a wide FOV 
with minimal artifacts. For dynamic imaging, there is a need for a high-speed scanning platform 
that can replace at least one of the slower galvo scanning mirrors. This is often accomplished by 
replacing the fast axis galvo scanning mirror with either a resonant scanning mirror [49] or a 
polygonal scanning mirror [50]. While these approaches offer less positioning accuracy than the 
galvo scanning mirror, they present a significant speed advantage allowing line scan rates of over 
several kilohertz (kHz), typically necessary for video-rate scanning microscopy. 
2.5.3 Detection electronics and data acquisition systems 
Finally, the detection and data acquisition systems of a 2PF and 2P-FLIM microscope are needed 
to convert the fluorescence light generated from the sample into an electrical signature that can be 
constructed into an image by the acquisition PC. Most modern 2PF microscopes utilize 
photomultiplier tubes to detect individual photons through a process known as photon counting 
[51]. This technique relies on setting a threshold value and counting incoming photons as 
individual events when this threshold is exceeded as is shown in Figure 2.10. While it is possible 
to instead directly record the analog photocurrent generated by the PMT in response to 
fluorescence light, the weak signals typically generated by 2PF microscopy systems make the 
photon counting approach significantly less susceptible to noise due to the thresholding procedure. 
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However, in the case of dynamic imaging under conditions of larger signals, this approach cannot 
typically be utilized. This is because photon counting places a restriction that the generated signal 
must be sparse in the time domain, meaning that the incoming rate of photons must be slow enough 
that the individual photons can be temporally resolved. This, in turn, when used for high-speed 
imaging, limits the dynamic range of the acquired data leading to poor quality images.  
 
Figure 2.10 Photon counting procedure for 2PF microscopy. Light incident on the detector will generate a small 
photocurrent that is amplified and compared to a threshold value by a high-speed discriminator. The resulting pulses, 
generated when the photocurrent exceeds this threshold, are counted individually and each pixel of the image is 
generated from the total counts over the dwell time of the pixel. 
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Thus, for most video-rate 2PF systems a direct sampling approach is typically utilized where the 
analog signal from the PMT is directly sampled using a high-speed analog-to-digital converter and 
sent to the acquisition PC where the image can be constructed by time-averaging the signal over 
the duration of each pixel [52]. 
This situation is further complicated in the case of 2P-FLIM imaging for which the fluorescence 
decay curve must be measured with sub-nanosecond temporal resolution. In modern 2P-FLIM, 
especially when used with weak fluorophores such as NADH, the most widely used detection 
method is known as time-correlated single photon counting (TCSPC) [53]. With this method, the 
arrival times of single photons are individually and sequentially recorded at every pixel in 
reference to the excitation laser pulse to construct a histogram estimating the fluorescence decay 
profile as shown in Figure 2.11. Due to the photon counting approach as well as the need for 
relatively low fluorescence photon count rates that are required for the detection electronics and a 
high number of collected photons for sensitive analysis of NADH lifetimes, TCSPC for NADH 
metabolic imaging has a speed restriction currently requiring pixel dwell times potentially on the 





Figure 2.11 Detection principle of TCSPC. The fluorescence decay curve is estimated through repeated measurements 
of single time-tagged photons, resulting in a histogram plot of arrival times [54]. 
One approach to increasing the speed of fluorescence lifetime measurements is to perform 
widefield imaging where measurements are made at all pixels simultaneously. Indeed, early 
fluorescence lifetime imaging instrumentation relied on the use of widefield frequency-domain 
measurements obtained in parallel. With increasing bandwidth in both cameras and image 
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intensifiers, video-rate fluorescence lifetime imaging can routinely be performed with this 
technology [55]. Recently, widefield ultrafast photography techniques have additionally been 
applied to FLIM. One such technique, capable of imaging at 100 billion FPS shows the capability 
to fully resolve the fluorescence decay dynamics time resolution on the order of 10 nanoseconds 
[56]. While widefield measurements present a huge increase in speed due to the parallel nature of 
the measurement, combination with 2PF is difficult due to the large excitation intensities needed, 
and deep tissue imaging is also challenging due to the large amount of optical scattering and 
crosstalk present when imaging biological tissue. 
Recently, several strategies have been implemented to increase the throughput of 2P-FLIM 
systems by using analog measurements [57, 58]. In particular, recent methods building upon direct 
waveform recording techniques have been developed [57, 59, 60], that have previously seen use 
in single-photon fluorescence lifetime imaging [61]. These techniques have shown great promise 
in increasing the acquisition rate of 2P-FLIM at the cost of decreased lifetime sensitivity and 
signal-to-noise ratio (SNR), compared to TCSPC. However, this imaging approach has not yet 
been extended to NADH metabolic imaging of cells and tissues, which remains challenging 
compared to fluorescent tags or dyes due to the low fluorescence efficiency of NADH and the need 
for sensitive and accurate lifetime extraction to obtain metabolic contrast. 
2.5.4 Data analysis 
As discussed previously, the data acquired from 2P-FLIM systems results in a temporally resolved 
fluorescence decay measurement at each pixel of the recovered image. When used for NADH 
imaging, this results in a biexponential decay process corresponding to the free and protein-bound 
states of NADH as described in Eqn. (2.8). This measurement is also affected by presence of the 
response function of the system, known as the instrument response function (IRF), that represents 
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the response of the 2P-FLIM detection system to an impulse. Following linear systems theory, this 
results in a measurement that can be modeled as 
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where h(t) is the system IRF and   represents the convolution operation. The IRF has the effect 
of broadening the width of the measured decay function, which can lead to errors in the lifetime 
estimation if not accounted for during the analysis procedure. 
In 2P-FLIM analysis, the main goal is to recover the parameters of Eqn. (2.10) with high accuracy 
in order to assess the relative contributions and lifetimes of free and protein-bound NADH. Given 
this model, there have been several methods developed that primarily fall into either statistical 
fitting procedures or fit-free approaches. 
To begin, the most direct form of 2P-FLIM analysis is to use the model of Eqn. (2.10) to directly 
fit the obtained fluorescence decay measurements at each pixel using a nonlinear least-squares 
approach such as the Levenberg-Marquardt algorithm [62]. Nonlinear least-squares is required 
here due to the nonlinearity of Eqn. (2.10) that arises from the convolution with the system IRF. 
This approach features several advantages including ease of implementation with existing 
statistical analysis software packages, ability to account for the system IRF to obtain accurate 
measurements, and capability of parallel processing utilizing the graphics processing unit (GPU) 
of the PC [63]. However, this approach is limited by the speed of the iterative nonlinear least-
squares fitting approaches that are typically utilized. Additionally, for a biexponential model, the 
number of degrees of freedom is large, requiring a high SNR (total photon count) to obtain a 
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reliable, accurate fit to the model. Finally, the reliance of this model limits the extent to which 
complex environments can be analyzed. For example, the presence of other small contributions 
from tissue fluorophores can greatly interfere with the extracted lifetime values obtained from 
direct fitting using Eqn. (2.10). 
In contrast to this statistical fitting approach, several fit-free 2P-FLIM analysis methods have been 
developed. Perhaps the most notable of these is the phasor approach to FLIM [64]. The phasor 
approach utilizes a graphical model based on a frequency-domain analysis method taking 
advantage of the speed of the fast Fourier transform (FFT) procedure. This graphical approach 
allows visualization and some quantification of the fluorescence lifetime properties of a sample 
with high-speed due to the use of the FFT algorithm and fit-free approach. Additionally, the 
capability of this approach to observe additional fluorescence species outside the scope of the 
model of Eqn. (2.10) has been demonstrated, identifying endogenous biomarkers for oxidative 
stress in addition to endogenous NADH in adipose tissue [65]. However, these techniques are 
typically primarily utilized for graphical representation and while quantification can be performed, 
model-based fitting approaches are likely to provide more accurate quantification of specific 
fluorescence lifetime features. 
2.6 Metabolic imaging of cell death 
Apoptosis, or programmed cell death, is a fundamentally important process in the maintenance of 
healthy cell populations in living organisms [66]. Pathological alterations in apoptotic pathways 
can lead to many disorders both in the case of increased levels of apoptosis, as in Alzheimer’s 
disease [67], as well as in the case of decreased levels of apoptosis, which is common during the 
progression of many cancers [68, 69]. Necrosis, a form of acute cell death [70], can be well 
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differentiated from apoptosis based on cellular energy consumption. Specifically, apoptosis is 
characterized by a coordinated, energy-regulated process that results in successful clearing of the 
cell without an appreciable immune response, while necrosis is an acute process that ultimately 
results in the rupture of the cell membrane causing an inflammatory response due to the leakage 
of intracellular materials into the extracellular space [71].  
Methods for the detection of cell death have been developed and utilized for in vitro studies of 
cultured cells [72, 73], preclinical small animal studies [74], and even for clinical trials [75, 76]. 
The discovery of cell death-related biomarkers has enabled the in vitro study of numerous 
pathways associated with apoptosis and necrosis. These studies have paved the way for detection 
of apoptosis in clinical settings which can be performed in vivo with SPECT or PET imaging using 
radiolabeled annexin V, a molecule which has a nanomolar affinity for membrane-bound 
phosphatidylserine (PS) specific for the cell membrane of apoptotic bodies [77, 78]. More recently, 
noninvasive, label-free methods have been adopted to microscopically identify and quantify 
important parameters of cell death. These methods include ultrasound imaging [79-81], dynamic 
light scattering [82], Raman scattering [83], and 2PF microscopy of NADH [84]. 2P-FLIM of 
NADH has shown promising results for longitudinally tracking the metabolic processes during 
cell death [17, 18, 20]. While 2PF microscopy and 2P-FLIM have been successfully used 
previously in tracking cell death in vitro or in assessing the metabolic state of in vivo tissue, they 
have not yet been extended to specifically identify and track cell death in vivo, which presents an 
important challenge in clinically translating this approach and technology. Additionally, previous 
2P-FLIM imaging studies of in vitro apoptosis induction with STS have observed extremely rapid 




Figure 2.12 2P-FLIM metabolic imaging of apoptosis in vitro. HeLa cells, following treatment with 1 µM STS, exhibit 
a rapid increase in NADH lifetime that is observed to persist at approximately 11 hours following treatment. Figure 
adapted with permission from [17]. 
These studies, relying on a commercial TCSPC detection platform were not able to fully capture 
these early dynamics due to the inherent speed limitations of TCSPC discussed above, further 
motivating the development of a new approach to dynamic 2P-FLIM metabolic imaging. 
Furthermore, these utilized techniques present a relatively low throughput approach to metabolic 
profiling as only a few cells can be analyzed with images acquired on the order of several minutes. 
To demonstrate the potential of 2P-FLIM apoptosis imaging as a clinical screening tool, the ability 
to image and profile a large number of cells at high speed is necessary. This is especially important 
for cancer therapeutic screening, where the presence of small amounts of drug-resistant 
subpopulations, which may be overlooked by low throughput techniques, can play a large role in 
the overall treatment decisions and patient outcomes [85]. 
Thus, while 2P-FLIM metabolic imaging of cell death has been demonstrated as an incredibly 
sensitive tool for apoptosis identification and tracking, overcoming these critical limitations is 
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important both for assessing metabolic imaging as a high-throughput therapeutic screening tool as 
well as in better understanding the complex role of metabolism in cell death pathways.  
2.7 Metabolic imaging of neural activation 
An enormous supply of energy is required following brain activation, which is met by increased 
levels of both oxidative phosphorylation and glycolysis [86]. One of the first surprising discoveries 
in brain metabolism was the observation that following brain activation, the rate of glucose 
consumption is increased greatly compared to oxidative metabolism [87]. This discovery has been 
explained as a short-term increase in aerobic glycolysis to convert glucose to lactate where it can 
later be oxidized, instead of complete oxidation of glucose through oxidative phosphorylation. 
Controversy has arisen, however, in the roles that various cells in the brain have in undergoing 
these processes. Due to this, NADH fluorescence imaging has been a heavily utilized tool in the 
current approach to studying this poorly understood behavior. The first reported measurement of 
NADH fluorescence transients in brain tissue was reported in 1973 by Lipton [88]. In this study, 
the first discussion of the characteristic biphasic curve of NADH fluorescence in neuronal tissue 
was made as demonstrated in Figure 2.13. When longitudinally analyzing the NADH fluorescence 
intensity levels of active neural tissue in response to brain stimulation, two key features can be 
clearly observed. First, within seconds following stimulation, there is a large decrease in the 
NADH intensity, known as the “dip” phase, that is followed by a slower recovery and long-lived 




Figure 2.13 First observation of the biphasic NADH fluorescence response to neuronal activation. The fluorescence 
plot (shown here with increasing fluorescence intensity in the downward direction) shows that following electrical 
stimulation (shown by arrows beneath the respiration plot), a large decrease or “dip” in fluorescence occurs that is 
followed by a slower increase in fluorescence denoted as the “overshoot” phase. Figure adapted with permission from 
[88]. 
Since this fascinating discovery, NADH and FAD fluorescence imaging of brain slices has become 
a commonly used research tool as a marker for neural activity [21, 89]. Simultaneously, there has 
been a critical debate on the cellular basis of this biphasic response and the connection to lactate 
production. The debate centers on the cellular basis of energy pathways and the respective 
contributions of these cells to the biphasic NADH fluorescence response upon neural activation. 
One proposed theory, known as the astrocyte-neuron lactate shuttle (ANLS) hypothesis, proposes 
that following brain activation, the main energy substrate for neurons, which are known to rely 
heavily on oxidative phosphorylation, is lactate produced by glycolysis in astrocytes following 
glutamate uptake [25]. This suggests that these aerobic and anaerobic energy production processes 
primarily occur in neurons and astrocytes respectively in the brain and that these cells cooperate 
to efficiently produce enough energy to support the firing of action potentials. Figure 2.14 shows 
 32 
  
this proposed process and the effects on metabolic processes. The ANLS theory proposes that 
following neuronal activation, the strong demand for ATP by neurons to support further activity 
causes a large increase in the rates of oxidative phosphorylation, causing an immediate, dramatic 
decrease in NADH intensity as observed in Figure 2.13. After a small time delay, glutamate uptake 
in astrocytes drives an increase in astrocyte glycolysis, causing an increase in NADH levels at later 
time points as has also been observed as part of the biphasic response shown in Figure 2.13.  
 
Figure 2.14 Pictorial description of the ANLS theory of energy production in the brain. The theory proposes that 
following neuronal stimulation, energy production in neurons is primarily through oxidative phosphorylation and that 
astrocytes will undergo glycolysis to produce lactate that is shuttled to the neurons as a primary substrate for further 
aerobic metabolism. Figure adapted from [90]. 
Through the use of 2PF microscopy of NADH in hippocampal slices, Kasischke et al. provided 
some of the first high-resolution microscopic evidence that the “oxidation” phase of the 
characteristic biphasic response was associated with neuronal oxidative phosphorylation, while the 
“overshoot” phase was associated with astrocytic glycolysis adding support to the ANLS 
hypothesis [26]. These results, however, have since been challenged by many researchers based 
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on the lack of direct imaging differentiation of neural cell types as well as further evidence that 
seems to dispute the ANLS theory finding that both neurons and astrocytes independently 
contribute to both aspects of the biphasic response.  
One particularly interesting study was focused on using an exogenous cytosolic NADH:NAD+ 
FLIM probe to study the redox dynamics during neuronal activation [23]. The results of this study 
showed that the intracellular NADH:NAD+ ratio initially increased immediately after stimulation, 
followed by a decrease back to the baseline value, suggesting that neuronal activation actually 
triggers glycolysis in neurons. The conflicting results of these studies provide further motivation 
for the development of new imaging tools that can track these dynamic metabolic processes. Due 
to the fact that 2PF NADH intensity imaging is not capable of directly measuring intracellular 
NADH concentrations, it is quite difficult to determine dynamic shifts in aerobic and anaerobic 
metabolism. In contrast to this, 2P-FLIM is ideal for sensitively identifying these metabolic shifts 
which lead to dramatic changes in the observed lifetime values. Thus, the development of a 
dynamic 2P-FLIM imaging platform for studying these metabolic interactions presents a powerful 
approach to studying this complex metabolic environment.
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3  IN VIVO METABOLIC IMAGING OF CELL DEATH INDUCTION 
3.1 Introduction 
As discussed in Chapter 2, programmed cell death is a critical process important in both 
homeostasis as well as in the treatment of many cancers. While previous work has highlighted the 
important relationship between apoptosis induction and rapid, dramatic increases in NADH 
fluorescence lifetime [17, 20], the application of 2P-FLIM imaging of NADH to image the in vivo 
metabolic dynamics associated with apoptosis induction has not yet been demonstrated. 
In this chapter, a 2P-FLIM imaging approach is developed to image endogenous intracellular 
NADH and to longitudinally track and distinguish apoptotic skin cells from necrotic and healthy 
cells beneath the intact skin surface in an in vivo hairless mouse model. Analysis of the longitudinal 
dynamics and metabolic parameters from obtained data enable differentiation of these death modes 
in vivo with cellular level resolution. These intrinsic biomarkers may prove highly beneficial in 
the translation of the next generation of therapeutics by permitting the noninvasive investigation 
of metabolic dynamics and therapeutic responses in individual cells. 
3.2 TCSPC-based 2P-FLIM metabolic imaging platform 
A custom-built multimodal optical microscope capable of both 2PF and 2P-FLIM imaging 
described previously [46] was utilized here to study the in vivo apoptosis microenvironment. This 
custom-built 2P-FLIM platform shown in Figure 3.1 can provide metabolic information regarding 
the skin microenvironment with cellular resolution and depth-resolved sectioning. Excitation light 
was provided by a Ti:sapphire laser (MaiTai HP, Spectra Physics) centered at a wavelength of 730 
The contents of this chapter are based on reference [113]: Bower et al. J. Biophotonics (2017). 
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nm, which was focused into the epidermal keratinocyte layers (approximately 5-20 µm beneath 
the skin surface) of intact, living mouse skin using a high NA objective lens (XLUMP20X, 
Olympus). The optical power at the focus was less than 7 mW. The focal spot was raster scanned 
across the sample using a pair of computer-controlled galvo mirrors (Micromax 671, Cambridge 
Technology). Detection of fluorescence was performed using a 16 channel PMT spectrometer 
(PML-16-C, Becker-Hickl) centered at 450 nm in order to capture NADH fluorescence. 
Fluorescence lifetime data were acquired through a commercial TCSPC data acquisition board 
(SPC-150, Becker-Hickl) capable of acquiring sensitive, high temporal resolution decay curves. 
 
Figure 3.1 Custom-built TCSPC 2P-FLIM system diagram. Abbreviations: M – mirror; G – galvo mirror; L – lens; 
TL – telescoping lens; DM – dichroic mirror; O – objective lens; S – sample; FB – fiber bundle; PMTS – PMT 
spectrometer; TCSPC – time-correlated single photon counting system. 
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3.3 Experimental design for in vivo apoptosis tracking and imaging 
In this study, a hairless mouse model (SKH1-Elite, Charles River) was used to investigate the 
longitudinal metabolic changes following chemical treatment to induce different forms of cell 
death. This animal model is the most widely used mouse model for dermatological research [91]. 
All studies were conducted under a protocol approved by the University of Illinois at Urbana-
Champaign Institutional Animal Care and Use Committee (IACUC). All animals were 
anesthetized using isoflurane gas (3% induction, 2% maintenance). Animals remained under 
anesthesia for the duration of the experiment. All groups received an intraepidermal injection in 
the dorsal region of the body. 
Animals were separated into three groups. One group of animals (N = 2) received an injection of 
100 µL saline and served as a control. Apoptosis (N = 5) was induced with a solution of combined 
200 µM camptothecin and 500 µM etoposide prepared in a 100 µL volume. Necrosis (N = 3) was 
induced with a 100 µL injection of 100 µM hydrogen peroxide. Camptothecin and etoposide, when 
used in concert, are well documented to induce apoptosis in a wide variety of cell types, including 
keratinocytes [18, 84, 92]. Similarly, hydrogen peroxide has been shown to cause necrotic cell 
death at high doses, consistent with what was used in this study [70]. Thirty minutes following 
treatment, animals were imaged with the 2P-FLIM microscope described above. Epidermal 
keratinocytes were imaged by focusing the excitation beam of the microscope just beneath the 
surface of the stratum corneum in the epidermis. Each animal was imaged every 15 minutes for a 
total of three hours following the injection. This imaging duration was chosen such that the same 
cells could be imaged for as long as possible while minimizing the risk associated with long-term 
anesthesia of the animals. The imaging site was located approximately 200-500 µm away from the 
injection site to avoid the potential effects of the injection process on the sensitive metabolic 
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imaging. Following imaging, animals were sacrificed, and skin samples were harvested for 
histological analysis. 
Data analysis was performed for 2P-FLIM images using the SPCImage software package (Becker-
Hickl). Using this software, the biexponential fluorescence decay model of Eqn. (2.10) was fit to 
the recorded FLIM dataset at each pixel in order to recover the parameters of interest including the 
mean fluorescence lifetime, relative amplitudes of both free and protein-bound NADH (A1 and 
A2), and excited state lifetimes of free ( 1 ) and protein-bound ( 2 ) NADH. Color-coded images 
were constructed based on these calculated values. In general, more red hues in these images 
represent lower values of these FLIM parameters while more blue hues represent increased values 
of the FLIM parameters. Statistical analysis was performed by isolating cells from artifact-free 
regions in each image and segmenting each cell individually using a customized CellProfiler [93] 
pipeline using an intensity-based segmentation algorithm. The metabolic parameters of interest 
were then extracted from the regions provided by these segmented cells. Statistical analysis for all 
comparisons was performed via one-way ANOVA followed by Tukey’s post-hoc test to make 
comparisons across the apoptosis, necrosis, and control cells. Data are presented in all cases as 
means ± standard error. 
3.4 In vivo cellular identification of apoptosis in keratinocytes 
For each imaging session, 2PF intensity images were used to obtain information about the 
keratinocyte structure and morphology as well as provide a measure of the relative concentration 
of NADH in the region under investigation, while the time-resolved fluorescence decay curves 
acquired at each pixel in the image provided functional, metabolic information regarding the 
relative binding of NADH. Figure 3.2a shows the longitudinal tracking of the mean fluorescence 
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lifetime of NADH in mice with locally induced apoptosis and necrosis in the skin, with 
representative datasets from each group at 30 minute intervals (Figure 3.2a). 
 
Figure 3.2 In vivo mean fluorescence lifetime dynamics in murine keratinocytes. (a) Images of the mean lifetime 
tracked between 30-180 minutes following treatment for inducing apoptosis or necrosis in epidermal keratinocytes. 
Saline-treated mice were used as a control. (b) Comparison of the mean lifetime (τm) in cells across the observed 
experimental population 30, 90 and 180 minutes after the treatment. At each time point, N = 34 cells analyzed for the 
apoptosis group, N = 14 cells analyzed for the saline group and N = 23 cells analyzed for the necrosis group. ** p < 
0.01 compared to the other two groups. Scale bar is 25 µm. All error bars represent SEM. 
Data from the saline-treated mice were used as a control. This mean lifetime metric can be 
considered as the concentration weighted average of the free and bound NADH lifetime. The 
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statistical analysis of the mean lifetime parameter across the entire observed cell population 30, 90 
and 180 minutes after the treatment showed that the mean lifetime in animals with induced 
apoptosis was significantly increased at each of these time points compared to both the animals 
with induced necrosis and the control group (Figure 3.2b).  
These results can be explained mechanistically by the role of active energy production, primarily 
in the form of oxidative phosphorylation in the programmed cell death process described 
previously in cell culture studies [93, 94]. These results compare favorably with previous in vitro 
studies that also reported a significant increase in the mean lifetime of NADH associated with 
apoptosis and no significant changes in the mean lifetime associated with necrosis, suggesting that 
these in vitro results are strongly reflective of the in vivo effects of apoptosis induction.  
The ability to identify and track apoptosis in single cells in vivo has two major implications for the 
use of 2P-FLIM as a tool for monitoring cell death. First, the fact that previous in vitro models 
exhibit effects remarkably similar to those of the metabolic dynamics observed in vivo suggests 
that an in vitro model can be utilized to enable the detailed study of the metabolic dynamics of 
apoptosis with high confidence that these results are reflective of the in vivo cellular response. 
While in vivo optical microscopy is very challenging for the noninvasive study of the induction of 
apoptosis in the tumor microenvironment, the use of in vitro models can allow highly sensitive 
and controlled study of the metabolic dynamics of apoptosis under various conditions, such as in 
drug-resistant cells for example [95].  
Additionally, while in vivo imaging is challenging, multiple minimally invasive techniques have 
been developed to enable optical microscopy to be utilized in the tumor microenvironment in vivo. 
For example, the development of in vivo mammary window tumor models for mice and rats has 
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enabled longitudinal study of high-resolution optical microscopy of the tumor microenvironment 
[96]. This approach can similarly be extended to study the effects of therapeutic, apoptosis-
inducing compounds in the tumor microenvironment. In particular, the use of patient-derived 
xenograft models presents a fascinating future application of this technology [97]. In this approach, 
patient-derived cancer cells can be transplanted into an animal model to assess the therapeutic 
responses of a screen of treatments. While the efficacy is typically assessed via gross 
measurements of size and shape of the tumor area, the use of in vivo 2P-FLIM combined with an 
imaging window model presents an attractive alternative that can be utilized to observe cell death 
at the cellular level, potentially permitting the identification of drug-resistant cell populations that 
could be associated with cancer relapse, that may not be identifiable through short-term gross 
examination of the animal. In the long term, a highly-sensitive imaging approach such as this could 
provide a sensitive clinical tool for identifying the best treatment options for patients, minimizing 
the risk of cancer recurrence. 
3.5 Parametric analysis of lifetime metrics during apoptosis 
In order to further understand and confirm the mechanism responsible for the observed differences 
in the mean lifetime between apoptotic, necrotic, and control cells, the individual parameters in 
Eqn. (2.10) were isolated through extraction of the fit parameters of each fluorescence decay curve, 
allowing study of the effects of cell death on both the extent of NADH binding as well as potential 
alterations in the binding site of NADH. This type of analysis has been useful previously in better 
characterizing the binding dynamics of NADH [13] as well as distinguishing between NADH and 
NADPH, a less prominent endogenous fluorophore with nearly identical fluorescence properties 




Figure 3.3 Bound-to-free NADH concentration ratio dynamics of in vivo murine keratinocytes. (a) Images of the 
bound-to-free concentration ratio (a2/a1) tracked from 30 to 180 minutes following treatment for inducing apoptosis 
or necrosis in epidermal keratinocytes. Saline-treated mice were used as a control. (b) Statistical comparison of the 
bound-to-free NADH concentration ratio in cells across the experimental population. At each time point, N = 34 cells 
analyzed for the apoptosis group, N = 14 cells analyzed for the saline group and N = 23 cells analyzed for the necrosis 
group. * p < 0.05 compared to the other two groups, ** p < 0.01 compared to the other two groups. Scale bar is 25 
µm. All error bars represent SEM. 
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Figure 3.3 shows a comparison of these two cell death modes based on the ratio of protein bound-







. Color-coded images of the bound-to-free NADH ratio at 30 
minute intervals of representative datasets from each group illustrate the observed dynamics of the 
relative binding (Figure 3.3a). While the relative concentration of bound NADH in the necrosis-
induced and control cells appears to be relatively unchanged during the experiment, the cells in 
the apoptosis-induced mice show an increase in relative binding initially, which decreases at 90 
minutes and is then again observed to be elevated after 180 minutes. The statistical analysis across 
the entire observed cell population (Figure 3.3b) confirms that these trends closely match the 
dynamics observed in the mean lifetime. Statistically, a significantly increased ratio of bound-to-
free NADH concentrations is observed at 30 and 180 minutes (p < 0.01) as well as at 90 minutes 
(p < 0.05) after the induction of apoptosis compared to the other two groups. 
In contrast, lifetimes for both the free NADH (τ1; Figure 3.4) and the bound NADH (τ2; Figure 
3.5) show relatively little change for the duration of the experiment. While the necrosis-induced 
mice appear to have a broader distribution of lifetimes for bound NADH compared to the other 
two groups of mice, the metabolic dynamics of this group appear to be largely unchanged. The 
statistical analysis across the entire observed cell population shows a significant change only in 
the bound NADH lifetime (p < 0.05) at 30 minutes (Figure 3.5b), while no significant change is 




Figure 3.4 NADH free lifetime dynamics of in vivo murine keratinocytes. (a) Images of the free lifetime (τ1) tracked 
from 30-180 minutes following treatment for the induction of apoptosis or necrosis in epidermal keratinocytes. Saline-
treated mice were used as a control. (b) Statistical analysis of free lifetime in cells across entire experimental 
population. At each time point, N = 34 cells analyzed for the apoptosis group, N = 14 cells analyzed for the saline 





Figure 3.5 NADH bound lifetime dynamics of in vivo murine keratinocytes. (a) Images of the bound lifetime (τ2) 
tracked from 30-180 minutes following treatment for induction of apoptosis or necrosis in epidermal keratinocytes. 
Saline-treated mice were used as a control. (b) Statistical analysis of bound lifetime in cells across entire experimental 
population. At each time point, N = 34 cells analyzed for the apoptosis group, N = 14 cells analyzed for the saline 
group and N = 23 cells analyzed for the necrosis group. * p < 0.05 compared to the other two groups. Scale bar is 25 
µm. All error bars represent SEM. 
In addition to these parametric changes comparing across treatment groups, there is a particularly 
interesting trend in the apoptosis treated group occurring at 90 minutes post-induction. While the 
NADH lifetime dynamics in the necrosis-induced and control cells appear to be relatively 
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unchanged across the duration of the experiment, the cells in the apoptosis-induced mice show a 
statistically significant decrease in both mean lifetime and bound-free NADH ratio with significant 
change to the bound lifetime (Figure 3.6a and b). 
 
Figure 3.6 Comparison of metabolic dynamics of apoptosis-treated group at 30 and 90 minutes. Comparison between 
the (a) mean lifetime, (b) bound-to-free NADH ratio, and (c) bound lifetime in cells across the experimental population 
shows a significant decrease of both the mean lifetime and bound-to-free NADH ratio from 30 to 90 minutes. At each 
time point, N = 34 cells analyzed for the apoptosis group. Statistical testing was performed using the Student’s t-test. 
** p < 0.01 compared to 90 minutes. All error bars represent SEM. 
While previous reports have hypothesized that the increase in mean lifetime is associated with 
increased levels of oxidative phosphorylation, a detailed parametric analysis such as the one shown 
here has not yet been performed to confirm this. The results of this analysis suggest that while cells 
are initially undergoing apoptosis, the relative amount of binding of intracellular NADH has more 
significant an impact on the measured fluorescence decay curve than any change to the free or 
bound lifetime of NADH that may result from binding to different intracellular sites or through 
changing environmental conditions. This further confirms that the primary mechanism responsible 
for the significantly elevated mean lifetime is the relative increase in mitochondrial-bound NADH, 
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which is likely due to an increased level of mitochondrial activation and aerobic metabolism 
associated with apoptotic cell death.  
It is also worth noting that the decrease in mean lifetime in the apoptosis-induced cells between 30 
and 90 minutes post-treatment can be primarily attributed to a significant decrease in the relative 
amount of protein-bound NADH compared to free NADH. This deviation is somewhat surprising 
as it has not been observed in any previous in vitro studies. The parametric analysis provides 
further insight into this highly-repeatable observation, suggesting a shift from increased aerobic 
metabolism towards glycolysis at 90 minutes post-treatment. This could potentially be a strong 
effect of the in vivo imaging environment. With a highly increased rate of aerobic metabolism, the 
requirement of oxygen and other key nutrients from the surrounding vasculature may not be met, 
causing this transient shift towards glycolysis in an attempt to produce the ATP required for 
programmed cell death. Additionally, the intracellular depletion of NADH observed in recent 
studies of apoptosis could explain these effects [99]. Specifically, the depletion of the intracellular 
NADH pool (complete mitochondrial oxidation of NADH) would appear initially as a large 
increase in the fluorescence lifetime of NADH due to the rapid binding and oxidation of NADH 
at complex I in the mitochondria, followed by a transient decrease after complete oxidation of 
mitochondrial-bound NADH. In order to continue generating ATP efficiently through oxidative 
phosphorylation, glycolysis levels would increase, further driving an observed decrease in 
fluorescence lifetime until enough NADH may be produced through glycolysis to sustain further 
oxidative phosphorylation, exhibiting a further increased fluorescence lifetime. The validity of this 
proposed mechanism could be further studied through the incorporation of other dynamic 
metabolic imaging tools such as redox imaging, combining the observations of NADH and FAD 
fluorescence in order to directly assess the redox state of the cell [100]. 
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3.6 Single-cell metabolic tracking of cellular apoptosis dynamics 
In order to identify the potential advantages of a cellular, in vivo approach to identify apoptosis, 
analysis of the longitudinal data was performed on three randomly selected single cells in addition 
to the population of cells sampled across the field of view of the acquired microscope images. The 
results of the single-cell analysis of in vivo keratinocytes treated with the apoptosis-inducing 
compound are shown in Figure 3.7. The boxed regions in the fluorescence lifetime image (τm) of 
the original field of view identify the three analyzed single cells (Figure 3.7a). Longitudinal mean 
lifetime images of these cells show the temporal metabolic dynamics of each cell analyzed at 15 
minute intervals for the full duration of the 3 hour experiment. Increased values of the mean 
lifetime can be observed after 180 minutes for all three cells, which is consistent with the general 
trend observed for the entire field of view (Figure 3.2)  as well as in the previous in vitro studies 
[17, 18]. The parametric analysis of each lifetime component was also applied to these cells (Figure 
3.7c-e). The mean lifetime (Figure 3.7c), bound-to-free NADH ratio (Figure 3.7d), and bound 
lifetime (Figure 3.7e) were each tracked as the average value of each parameter across the 
individual selected cells. After 60 minutes, a sharp decrease in mean lifetime is observed in cell 3 
that precedes the corresponding decrease observed in cells 1 and 2, followed by the continuous 
increase in all three cells for the remainder of the experiment. The ratio of bound-to-free NADH 
ratio exhibits very similar changes. The time discrepancy in observed changes between cells can 
be due to many local factors such as diffusion effects, or different baseline metabolic states of 
these cells. By probing single cells in vivo, this imaging approach has the potential to be utilized 
for identifying apoptosis-resistance subpopulations of cells, a critically important clinical need that 




Figure 3.7 Single-cell analysis of in vivo apoptotic keratinocytes. (a) Mean fluorescence lifetime image of the full 
field of view of the microscope of in vivo mouse skin treated with apoptosis-inducing compound. The three colored 
rectangles represent the image regions where individual cells were studied. (b) Longitudinal tracking of the mean 
lifetime from three cellular regions. Images are shown for each cell every 15 minutes up to three hours following the 
treatment. (c-e) Plots of the metabolic lifetime parameters of the three cells studied including the mean lifetime (c), 
bound-to-free NADH ratio (d), and bound lifetime (e). Scale bar is 25 µm. 
3.7 Confirmation of cell death 
Cell death was confirmed using standard histological staining of tissue samples with hematoxylin 
and eosin of the skin areas that were imaged with 2P-FLIM as shown in Figure 3.8. Standard 
hallmarks of apoptosis such as condensed nuclei as well as the loss of membrane integrity can be 
clearly observed in the skin samples treated with the apoptosis-inducing compound (Figure 3.8a) 
[102]. In the group treated with the necrosis-inducing compound, a complete loss of cellular 
structure can be observed in the affected area, a clear indication of necrotic cell death (Figure 3.8b). 





Figure 3.8 Histological confirmation of cell death induction in treated animals. (a) Apoptosis induction may be 
identified through the observation of condensed, pyknotic nuclei (red arrows). (b) Necrosis induction is associated 
with the complete loss of nuclei in the keratinocytes (blue arrows). (c) Saline-treated epidermal keratinocytes show 
normal appearance and morphology. All samples were stained using H&E and imaged under identical conditions. 
Scale bar is 25 µm. 
3.8 Conclusions 
In this chapter, a label-free 2P-FLIM imaging approach was developed to identify apoptosis in 
vivo with single-cell resolution. The obtained results show that the mean fluorescence lifetime of 
NADH is a suitable biomarker for tracking apoptosis in vivo. Most notably, the NADH mean 
lifetime shows a significant increase especially at later time points, which is in good agreement 
with previous in vitro studies of cell [17] and tissue [18] cultures. The approach employed here 
has enabled the successful translation of these methods in vivo, showing that these biomarkers can 
be used for label-free tracking of apoptosis in living organisms. Finally, the advantage of a cellular 
resolution imaging for identifying cell death was demonstrated by studying the heterogeneous 
response to an apoptosis-inducing agent in nearby cells, allowing for the assessment of the 
individual cellular responses. Therefore, the respective metabolic changes can be probed and 
studied in the real time in their natural environment in order to identify apoptosis in single cells.  
One critically important aspect of continuing work is to extend this imaging approach to 
investigate the metabolic dynamics associated with other apoptosis pathways. Apoptosis generally 
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occurs through either the intrinsic mitochondrial-mediated pathway, studied here, or through the 
extrinsic death receptor-mediated pathway [103]. In this extrinsic pathway, the binding of ligands 
to specific cell membrane death receptors leads to the activation and cleavage of caspases 
necessary to carry out apoptosis. 2P-FLIM of NADH has not yet been applied to investigate this 
secondary pathway, likely due fact that it is independent from the mitochondrial-mediated pathway 
that can be directly observed. However, recent studies suggest that mitochondria still play a crucial 
role in coordinating apoptosis even when occurring through the extrinsic pathway [104]. 2P-FLIM 
of NADH presents an opportunity to further explore these connections and better understand the 
complex machinery of the apoptosis process. 
Moving forward, it will be critical to temporally correlate in time these in vivo observations to the 
molecular hallmarks of apoptosis using sensitive methods such as immunohistochemistry as is 
common to study the apoptosis process in vitro [20]. Specifically, it is critically important to 
understand the interaction between the large increase in aerobic metabolism observed from 2P-
FLIM NADH imaging and the processes of caspase activation, mitochondrial membrane pore 
formation, and the release of cytochrome c. It is hypothesized here that the increased aerobic 
metabolism of the cell will be upstream of these processes in order to generate the large amounts 
of ATP necessary to fuel these critical events, but future study combining sensitive molecular 
assays with the 2P-FLIM imaging technique described here will be necessary to confirm or refute 
this theory. 
In addition, further study of these intrinsic biomarkers can also be used to identify pathological 
alterations of cell death pathways, which is essential to better understand the progression of many 
diseases. Of critical importance in this effort is the identification of metabolic signatures that are 
both sensitive and specific to apoptosis. While this technique has been shown to be a highly 
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sensitive in vivo tool to observe apoptosis, the specificity must be further quantified. This can 
potentially be performed through 2P-FLIM imaging in combination with the use of small doses of 
apoptosis-inducing compounds that will result in a significant population of cells able to survive 
the apoptotic stimulus. Through careful analysis under these conditions, potential markers of both 
survival and death may be extracted in order to further assess the capabilities of the fluorescence 
lifetime of NADH as a biomarker for apoptosis. One such potential marker may be the early, rapid 
NADH lifetime dynamics associated with apoptosis, which is the major focus of Chapter 5 of this 
thesis. 
Importantly, while this approach shows the high sensitivity of traditional 2P-FLIM imaging 
systems, it is worth noting that the early metabolic dynamics of apoptosis, occurring almost 
immediately following treatment, are difficult to track with such an imaging system, mainly due 
to the speed limitations of TCSPC. As can be seen from Figure 3.2, the NADH mean lifetime, 
captured by the TCSPC-based imaging system used for this study, is observed to be significantly 
increased even at the earliest time points without the ability to capture the rapid metabolic 
dynamics that must have occurred to result in such a change. These results provide further 
motivation to develop a high-speed imaging platform able to resolve and investigate the early 
metabolic dynamics following apoptosis induction. The development of such a system is the 
primary focus of Chapter 4, and its direct application to study these dynamic effects further is 




4 HIGH-SPEED LABEL-FREE METABOLIC IMAGING 
4.1 Introduction 
In the previous chapter, a TCSPC-based 2P-FLIM approach was used to probe with high sensitivity 
the long-term dynamics associated with apoptosis induction in vivo. Label-free optical metabolic 
imaging techniques capable of probing the energetic pathways within cells, such as 2P-FLIM 
imaging of NADH, have had an important impact on understanding the role of metabolism in 
complex tissue microenvironments and in elucidating metabolic disorders associated with many 
diseases [10]. Despite the wealth of information provided by 2P-FLIM for metabolic imaging, 
conventional methods for high-sensitivity imaging are burdened by slow acquisition rates due to 
the photon counting process used in TCSPC, limiting the study of transient metabolic dynamics in 
living cells.  
In this study, a high-acquisition-speed, label-free 2P-FLIM system is developed specifically to 
address these challenges for NADH metabolic imaging and is used to investigate rapid changes in 
metabolic pathways in living cells and tissue as well as to investigate metabolism across large 
tissue areas, overcoming traditional speed limitations in high-resolution metabolic imaging and 
providing a unique tool to study metabolic dynamics with subcellular resolution. 
4.2 High-speed 2P-FLIM microscope development 
The system diagram of the developed high-speed 2P-FLIM system is shown in Figure 4.1. The 
laser excitation is provided by a mode-locked Ti:sapphire laser (Spectra-Physics Mai Tai HP) 
centered at 750 nm for NADH imaging. The beam is scanned across the sample by a galvo-
The contents of this chapter are based on reference [116]: Bower et al. Optica (2018). 
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scanning mirror (Cambridge Technology) for the slow axis and an 8 kHz resonant scanning mirror 
(EOPC SC-30) for the fast axis. For imaging, only data from the central portion of the resonant 
scanning mirror sweep was acquired to minimize distortions from the sinusoidal scan pattern. After 
the scanning mirrors, the beam is expanded through a 1:3 magnification telescope and focused by 
a high numerical aperture water-immersion objective (Olympus XLPLN-25X-WMP2 - 1.05 NA; 
25x magnification) onto the sample. The emitted fluorescence light is collected by the same 
objective, reflected by a dichroic mirror, and passed through a bandpass fluorescence emission 
filter (450 ± 70 nm; Semrock Brightline FF01-450/70-25) onto an analog photomultiplier tube 
(PMT) (Hamamatsu H10721-20) operating at a gain level of approximately 106, ensuring that only 
fluorescence light from the sample is collected.  
 
Figure 4.1 High-speed 2P-FLIM system design. Abbreviations: BS – beamsplitter; PD – photodiode; M – mirror; RM 
– resonant mirror; GM – galvo mirror; TL – tube lens; DM dichroic mirror; OL – objective lens; S – sample; PMT – 




The signal from the PMT is sent through a high bandwidth transimpedance amplifier (Hamamatsu 
C5594 – 1.5 GHz bandwidth) and directly digitized using a 12-bit, 1.8 gigasamples per second 
digitizer (AlazarTech ATS-9360). 
Direct synchronization of the digitizer sampling clock and scanning mirrors to the laser pulse 
repetition clock is necessary to ensure time-locked sampling of each image as shown in Figure 4.2. 
The system clock is derived from the laser pulse train through direct measurement of the reflected 
beam by a 95/5 beamsplitter using an amplified photodiode (ThorLabs PDB450A).  
 
Figure 4.2 Data acquisition synchronization principle. The sample clocks of both the digitizer and scanning mirrors 
are synchronized at an integer multiple of the laser repetition rate (red pulses) as measured by an external photodiode. 
In doing so, the generated fluorescence from the sample (green curves) is sampled in phase at every laser pulse, 
allowing averaging over several pulses for each pixel in the image resulting in a high SNR fluorescence decay 
measurement. 
A 10 MHz reference clock obtained by downsampling the 80 MHz photodiode signal is provided 
to the digitizer, allowing synchronized control of the sampling rate that is phase-locked to the laser 
clock. An 8 kHz reference clock derived from the 10 MHz master clock is also provided to the 
resonant scanning mirror driver (EOPC PLD-1S) to ensure the synchronization between beam 
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scanning and data acquisition. Through synchronization of these systems, coherent averaging of 
decay curves from multiple laser excitations can be performed with minimal effects from phase 
drifting. A high-speed fluorescence intensity imaging display is implemented in order to find 
important regions of interest and to preview the structural information of the acquired 2P-FLIM 
datasets. As data is acquired at GB/s rates, a high write-speed hard disk is needed for fast, sustained 
streaming of raw data to disk. This is accomplished using a PCIE-based solid-state hard drive 
(Samsung 960 Pro with sequential write speed up to 2.1 GB/s) taking the place of the traditional 
SATA-based hard disk. Utilizing the PCIE interface allows streaming of data from the digitizer to 
the solid-state drive without encountering a major memory bottleneck, allowing video-rate 
recording of data over extended durations, limited only by the physical storage space of the solid-
state drive capacity, allowing potentially hours of raw data streaming at video rate. Fluorescence 
lifetime decay curves are constructed by averaging the individual synchronized fluorescence 
decays over the pixel dwell time of the excitation pulses. Typically for NADH imaging, the 
fluorescence decay is modeled as a biexponential function and can be estimated from these 
measurements by performing nonlinear least squares curve fitting along with deconvolution of the 
IRF. However, this curve fitting procedure can be challenging in the presence of high noise levels 
and in curves containing relatively few temporal data points. 
When combined with the large total amount of data collected, fitting and deconvolution of this 
data with a biexponential model are somewhat impractical. In lieu of this, the data is directly fit 
from the peak response to a single exponential model as shown in Figure 4.3, similar to processing 
methods performed in other high-speed imaging systems [57]. This is subsequently cast as a linear 
least squares problem, taking the form of a large linear system of equations to solve for the 
fluorescence lifetime. When analyzed in this manner, a 2-minute-long acquisition at 20 FPS (2400 
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datasets total) can be processed and analyzed in under 15 minutes using MATLAB with much of 
this processing time spent on reading large datasets into memory. All data, excluding lifetime 
fitting from standard fluorescent dyes where deconvolution was performed, were processed in this 
manner. Finally, color-coding of the 2P-FLIM data was performed by converting the lifetime 
values extracted at each pixel as a Red-Green-Blue (RGB) image into a Hue-Saturation-Value 
(HSV) image. By encoding the value channel of this image with the grayscale fluorescence 
intensity image, the resulting image, converted back to standard RGB, shows the co-registered 
structural and functional information from the fluorescence intensity and lifetime respectively as 
shown in the right panel of Figure 4.3. 
 
Figure 4.3 Schematic displaying the processing workflow for the high-speed 2P-FLIM data. Raw decay curves, as 
shown on the far left, are obtained from each pixel in the acquired image. From here, the early response of the detector 
is removed by starting analysis from the peak value. To fit the lifetime, the natural logarithm of the decay curve is 
computed, and a linear least-squares fit is performed at each pixel and used to color code the lifetime value for each 
pixel as shown in the image on the far right. 
4.3 System characterization 
To first assess the fluorescence lifetime contrast capabilities of the high-speed 2P-FLIM system, 
fluorescence decay curves were obtained from several standard fluorescent dyes including 
rhodamine B, 5’ carboxytetramethyl rhodamine (TMR), and fluorescein as shown in Figure 4.4a. 
Plots of these measured decays along with the IRF obtained through detecting second harmonic 
generation radiation from urea crystals show clear differences between the various fluorophores. 
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To assess the accuracy of these measurements, the decays were deconvolved and fit to a single 
exponential model using the empirical IRF to obtain a lifetime measurement for each dye. The 
inset of Figure 4.4a gives a direct comparison of the extracted lifetime values to previously 
reported values. The correlation between measured lifetime with this high-speed 2P-FLIM system 
and previously reported values indicates that the imaging system is capable of reliable lifetime 
contrast. 
To demonstrate the imaging capabilities of this system, 256 x 256 pixel 2P-FLIM images were 
acquired at 20 FPS of urea crystal, which is known to produce second harmonic generation (SHG) 
as shown in Figure 4.4b. The crystal structure with short lifetime values corresponding to the near-
instantaneous decay of the SHG process can be clearly visualized, confirming the high-resolution 
imaging performance of this system.  
 
Figure 4.4 Characterization of the developed high-speed 2P-FLIM system. (a) Representative fluorescence decay 
curves from standard fluorescent dyes. Inset plot shows extracted lifetime values compared to literature values for 
Rhodamine B [105], TMR [106], and Fluorescein [107]. (b) 2P-FLIM image of SHG signal from a urea crystal giving 
a measure of the response function of the system. Scale bar is approximately 10 µm. 
Next, in order to demonstrate the ability to obtain high-resolution fluorescence lifetime contrast, 
images were acquired from fluorescent samples and shown in Figure 4.5. To begin, fluorescently 
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labeled beads were used in order to demonstrate the high-resolution capabilities of the system 
(Figure 4.5a). These beads are approximately 1 µm in diameter and are known to have a 
fluorescence lifetime similar to that of fluorescein (approximately 4 ns). The high-speed 2P-FLIM 
system is able to recover this spatially resolved lifetime at high frame rates (20 FPS) to recover an 
accurate measure of the lifetime of these beads.  
 
Figure 4.5 High-speed 2P-FLIM imaging of fluorescent samples. (a) Image of fluorescently-labeled 1 µm diameter 
beads. (b) Label-free 2P-FLIM image of dog soft tissue sarcoma where strong contrast can be observed between the 
cellular autofluorescence (blue/green hues) and the collagen SHG emission (red hues). (c) Extracted fluorescence 
decay curves from regions of NADH autofluorescence from cells and SHG emission from collagen. Scale bar is 
approximately 50 µm in (a) and 25 µm in (b). 
Next, ex vivo dog soft tissue sarcoma tissue was imaged using the system to demonstrate the 
capabilities of label-free imaging (Figure 4.5b). This tissue specimen consists of small nests of 
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cells embedded in the fibrous collagen structure. The cells will emit NADH autofluorescence, 
which typically exhibits a mean lifetime of approximately 1-2 ns, while the collagen structure will 
generate an SHG signal similar to the urea crystal shown in Figure 4.4b. The lifetime contrast, 
further shown from the decay curves of Figure 4.5c, enables clear identification of cells within the 
surrounding extracellular matrix, demonstrating further the capabilities to obtain label-free 
contrast in tissue. 
To demonstrate the potential of this imaging platform specifically for NADH metabolic imaging, 
Figure 4.6 shows results of autofluorescence imaging of cells and tissue. A large field-of-view 2P-
FLIM mosaic was obtained from a 10 µm thick section of fixed rat testis tissue (Figure 4.6a). The 
acquisition was performed by acquiring a 10 x 10 mosaic of 250 x 250 µm field-of-view (FOV) 
images, with approximately 30 averages per stage position recorded at 20 FPS. These images were 
then merged together using MosaicJ, a stitching and blending plugin for ImageJ [108]. Previously 
in our lab, a similar mosaicing procedure was performed utilizing a TCSPC based approach 
requiring approximately 3 hours to acquire a 10 x 10 image mosaic [109]. Here, the full mosaic, 
spanning approximately 2 x 2 mm, can be acquired in approximately 2 minutes, representing a 
significant increase in throughput for 2P-FLIM autofluorescence imaging. It has been reported 
previously that the dominant autofluorescent components of this tissue are intracellular NADH 
and shorter lifetime elastin, present in the fibrous capsules surrounding the seminiferous tubules 
[110]. The shorter lifetime from elastin (Figure 4.6b white arrows) can be clearly observed, 





Figure 4.6 High-throughput NADH 2P-FLIM imaging. (a) Wide FOV mosaic of a fixed rat testis specimen acquired 
in under 5 minutes. (b) Zoomed region from (a) corresponding to red box. White arrows correspond to elastin 
fluorescence from the fibrous cap of the seminiferous tubules. (c) Lifetime histogram of the acquired mosaic. The 
large peak corresponds to the NADH fluorescence while the lower lifetime shoulder (blue arrow) corresponds to the 
elastin fluorescence. (d, e) High-speed NADH 2P-FLIM images of (d) MDA-MB-231 and (e) MCF-7 cells. (f) 
Statistical analysis comparing cytoplasmic lifetime from the two cell lines. Bar chart values represent mean ± s.e.m.  
(N = 17 for each group). Scale bar in (a) is 250 µm. Scale bar in (d, e) is approximately 50 µm. *p<0.01. 
By constructing a histogram of lifetime values from the pixels in this mosaic, the presence of these 
two fluorophores can be clearly identified as a large, longer lifetime peak, belonging to NADH 
and a shorter lifetime shoulder due to elastin (Figure 4.6c blue arrow). The speed of this imaging 
procedure can be potentially increased even further, by extending the FOV of a single frame (using 
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wider scan parameters) as well as averaging over a smaller number of images, trading off SNR for 
imaging speed. 
To determine the metabolic sensitivity of this system, in vitro cellular imaging was performed with 
two well-established breast cancer cell lines with distinct metabolic profiles, MDA-MB-231 
(Figure 4.6d) and MCF-7 (Figure 4.6e). MCF-7 is a noninvasive, less aggressive cell line known 
to rely more on oxidative phosphorylation than the highly aggressive MDA-MB-231 cell line that 
shows increased levels of aerobic glycolysis [111]. MCF-7 and MDA-MB-231 cells were plated 
in glass bottom imaging dishes (MatTek P35GC-0-14-C) in phenol red-free media (MEM alpha 
for MCF-7, Leibovitz’s L-15 for MDA-MB-231) supplemented with 10% fetal bovine serum and 
antibiotics. Cells were imaged within 72 hours of plating based on confluency. All imaging was 
performed in ambient conditions at room temperature as all imaging in these studies was 
completed within 30 minutes. Imaging results using the high-speed 2P-FLIM microscope reveal a 
statistically significant increase in cytoplasmic NADH fluorescence lifetime in MCF-7 compared 
to MDA-MB-231 cells (Figure 4.6f), showing clear sensitivity to the increased glycolytic activity 
in MDA-MB-231 cell line that has been reported previously [112].  
This observation highlights the capabilities for metabolic contrast with this high-speed 2P-FLIM 
approach. Functional mapping of individual cells with this high-throughput imaging system can 
provide new insight into metabolic pathways in cells and can be used to identify metabolic 
heterogeneity within complex cellular environments with the ability to sample a much larger 
number of cells than traditional TCSPC-based 2P-FLIM systems. In comparison to TCSPC, the 
metabolic contrast obtained is significantly less specific as biexponential decay curve fitting is 
unreliable. However, through fitting with a single exponential curve, the lifetime metric obtained 
can be considered to be similar to the mean lifetime as extracted from the biexponential TCPSC-
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based analysis. However, it is important to note that while this is a form of metabolic contrast, 
highly sensitive parametric analysis of intracellular free and bound lifetimes and relative 
contributions remains a challenge due to the lack of necessary temporal resolution to obtain high-
quality fits of the decay curves to a biexponential model. This can potentially be addressed through 
increased sampling rates and interleaved sampling schemes as will be discussed in Section 4.5. 
 
Figure 4.7 2P-FLIM imaging of apoptosis induction in MCF-7 cells utilizing the developed high-speed 2P-FLIM 
system. (a-d) images of (a and c) NADH intensity and (b and d) NADH lifetime at (a and b) 0 minutes and (c and d) 
15 minutes following STS treatment of MCF-7 cells. A large increase in both the NADH fluorescence intensity and 
lifetime is observed. (e) Cellular fluorescence decay curves at 0 minutes (red curve) and 15 minutes (blue curve) 
demonstrating this large increase in the decay time of the NADH fluorescence. 
As an additional validation of the imaging capabilities of this system, 2P-FLIM NADH imaging 
of apoptosis induction was investigated in MCF-7 cells. These cells were cultured under the same 
conditions as above and were imaged before and 15 minutes following the addition of 5 µM STS, 
a potent, fast-acting apoptosis-inducing compound. Results shown in Figure 4.7 reveal a large 
increase in both fluorescence intensity (Figure 4.7a and c) and lifetime (Figure 4.7b and d) 15 
minutes after addition of STS. Direct comparison of extracted fluorescence decay curves (Figure 
4.7e) shows the capabilities of this imaging platform to detect this large shift in metabolism. This 
provides further support for the use of this high-speed system to study and track the transient 
dynamics that occur almost immediately following STS treatment. 
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4.4 Video-rate metabolic imaging of apoptosis dynamics 
To further investigate this early response, the high-speed 2P-FLIM system was optimized for fast 
longitudinal imaging of living cells in vitro. The previous in vitro results of Figure 4.7 suggest a 
strong early NADH lifetime response to apoptotic stimuli within minutes of treatment. However, 
current TCPSC-based approaches could not further investigate this response due to imaging speed 
limitations [17, 18, 20, 113]. Apoptosis was induced in MCF-7 cells cultured as discussed 
previously with the addition of 5 µM STS approximately 10 seconds following the start of 2P-
FLIM imaging at 20 FPS for a total duration of approximately 2 minutes (Figure 4.8). Treatment 
with micromolar level doses of STS is well-documented to efficiently induce apoptosis in a 
majority of the MCF-7 cell population [114, 115]. Resulting images are displayed as averages over 
20 frames (one second).  
Snapshots of both fluorescence intensity (Figure 4.8a-c) and lifetime (Figure 4.8d-f) at 0 seconds 
(Figure 4.8a and Figure 4.8d), 20 seconds (Figure 4.8b and Figure 4.8e), and 70 seconds (Figure 
4.8c and Figure 4.8f) following the start of imaging show a statistically significant increase in both 
the fluorescence intensity (Figure 4.8i) and lifetime (Figure 4.8j) in analyzed single cells at 20 




Figure 4.8 High-speed 2P-FLIM of apoptosis induction in MCF-7 cells. (a-c) NADH intensity and (d-f) NADH 
lifetime images of apoptosis induction at time points of (a, d) 0 seconds, (b, e) 20 seconds, and (c, f) 70 seconds. (g) 
NADH fluorescence intensity and (h) lifetime dynamics in cells 1 and 2 as labeled in (c). (i, j) Comparison of NADH 
intensity (i) and lifetime (j) values at 0 and 20 seconds. Bar chart values represent mean ± s.e.m. (N = 16). Scale bar 
is approximately 50 µm. *p < 0.01. 
Immediately following the sharp increase after addition of STS, a decrease in NADH lifetime is 
observed, recovering to an elevated level compared to baseline (Figure 4.8h).  
To reduce the effect of the background and nuclear regions during image analysis, the cell 
cytoplasm regions from each cell were extracted and used for quantification of fluorescence 
dynamics through a segmentation procedure. Segmentation for single-cell analysis of Figure 4.8 
was performed using the software package CellProfiler [93] to isolate cell cytoplasm regions as 
shown in Figure 4.9. To begin, cellular regions were isolated in each image through a manual 
identification and segmentation procedure. Next, in order to exclude the nuclear regions of each 
cell, the nucleus from each analyzed cell was secondarily identified and segmented manually. 
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Finally, the identified nuclear region of each individual cell was removed, and each resulting cell 
was given a unique numerical labeling and exported as an N-ary image, where N is the total number 
of cells. From these images, longitudinal, cellular analysis of both the fluorescence emission 
intensity and lifetime can be performed to track the metabolic responses from individual cells.  
 
Figure 4.9 Overview of CellProfiler NADH cytoplasm segmentation pipeline. Raw images are manually segmented 
for both the cell membrane and nuclei of desired cells within the FOV. These two regions are then used to extract the 
cell cytoplasm and export an N-ary image for single-cell cytoplasmic analysis of longitudinal NADH fluorescence 
dynamics. 
Segmentation of NADH signals from the cell cytoplasm (segmentation map in Figure 4.8c) shows 
statistically significant increases in both fluorescence intensity (Figure 4.8i) and lifetime (Figure 
4.8j) comparing at 0 seconds and 20 seconds using a two-sample t-test. These results suggest a 
dramatic increase in NADH production evidenced by the increase in NADH intensity (Figure 4.8g) 
combined with dynamic changes in NADH binding provided by the high-speed time-resolved 
detection, indicating rapid shifts or disruptions to various steady-state metabolic pathways within 
seconds in response to the apoptosis-inducing stimuli. It is hypothesized here that the dramatic 
changes in the 2P-FLIM measurements seen at 20 seconds and 70 seconds in this dataset are related 
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to the large dose of STS used to induce apoptosis, which may place a large energy burden on the 
cell, potentially leading to saturation of NADH binding to complex I in the mitochondria. Another 
particularly interesting observation is found in the nuclei of these treated cells. Here, following the 
apoptosis-inducing STS treatment, a bright punctate pattern of fluorescence can be observed in the 
cell nuclei that has not been previously reported. Further study of this nuclear signal is necessary 
to understand the origin of this signal and the potential role of nuclear NADH in STS-induced 
apoptosis. 
Future study to further investigate the mechanism responsible for the observed dynamics is 
essential to understanding the relationship between apoptosis and dynamic changes in cell 
metabolism. It is important to note that this high-speed 2P-FLIM technique provides several 
benefits over high-speed two-photon fluorescence intensity microscopy approaches used 
previously for high-speed NADH imaging [52]. To begin, the fluorescence lifetime measurement 
is unaffected by fluorophore concentration providing highly-specific metabolic information about 
the instantaneous binding status of NADH regardless of the absolute concentration. In addition, 
for deep-tissue imaging, this technique has the added benefit of being relatively insensitive to 
tissue absorption and scattering, which can have a noticeable effect on the collected fluorescence 
intensity signal. This high-speed metabolic imaging platform is thus capable of providing deeper 
insight into the strongly coupled interactions between metabolic pathways of the cell and the 
complex process of apoptosis at the earliest time points, currently impractical with commercially 




While this approach offers new capabilities for optical metabolic imaging, several challenges 
remain. Most importantly, measurement accuracy and temporal resolution are relatively low 
compared to TCSPC, which is much more sensitive to shorter fluorescence lifetime decays, and 
the effect of the IRF is diminished, leading to better fit results. In addition, biexponential decay 
fitting, which is crucial for extracting free-and protein-bound contributions of NADH 
fluorescence, currently remains a key challenge with the high-speed 2P-FLIM system due to the 
low temporal resolution constrained by the speed of the digitizer. With increasing speeds of PC-
based digitizers as well as the incorporation of clever digitization schemes combined with 
utilization of fast, sensitive detectors such as multi-channel plate PMTs, these issues can be 
resolved, increasing the sensitivity of the system while still permitting video-rate acquisition. 
One such clever sampling scheme that could be employed in this system in a straightforward 
manner is the interleaved sampling scheme introduced to an analog 2P-FLIM system by Dow et. 
al. [57]. The basic overview of this technique is demonstrated in Figure 4.10. The basic idea of 
interleaved sampling is to sample at a non-integer multiple of the laser repetition rate. By doing 
so, the effect is to introduce a deterministic phase delay in the sampling clock relative to the laser 
clock with each new pulse, allowing higher sampling densities at the cost of repeated 
measurements. This approach enabled a 4x sampling rate increase without the need for any new 
hardware or data acquisition tools [57]. This approach can be similarly extended to the high-speed 
2P-FLIM instrument developed here with the incorporation of this interleaved sampling into the 
control software of the microscope. This increase in sampling rate will come at the expense of the 
imaging frame rate of the system. With higher desired sampling densities, more repeated 
measurements must be made, extending the necessary pixel dwell time. Thus, a customizable 
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strategy could potentially be employed as follows: when high resolution is needed, imaging speed 
could be decreased while increasing the sampling density, and when high imaging speed is 
necessary, the sampling density can be reduced. 
 
Figure 4.10 Demonstration of the proposed interleaved sampling scheme to increase the fluorescence decay curve 
sampling density. By selecting the appropriate digitizer sampling rate, the interleaved sampling of the periodic 
fluorescence decay curve at each pixel (top) can allow the construction of a densely sampled decay curve (bottom). 
The fast imaging performed here in addition with the weak fluorescence from NADH increases 
the potential risk of photodamage. While no apparent photodamage was observed in the analyzed 
regions of the datasets shown here, laser parameters such as central wavelength, repetition rate, 
and pulse energy must be optimized and studied in the context of cell viability to understand fully 
the effects of this imaging.  
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Finally, while the acquisition speed of this system is increased compared to traditional TCSPC, 
the current processing techniques utilized prevent real-time display of 2P-FLIM images. This can 
be potentially overcome through the use of fast, parallel algorithms utilizing the GPU of the PC or 
the field-programmable gate array (FPGA) of a fast digitizer, potentially allowing high-speed 
biexponential fitting of fluorescence decay curves [58]. The high-speed 2P-FLIM system 
presented here has the potential to enable a variety of biological and clinical studies. This new 
approach provides an important tool for investigating a wide variety of highly dynamic metabolic 
processes and disorders in living cells. Further development of this technology could further enable 
important but currently challenging tasks such as high-throughput label-free metabolic cell 
screening, paving the way for a deeper understanding of the metabolic processes underlying 
complex cellular activity, which is important for both basic biological research and clinical 
translation of these discoveries. The remainder of this thesis demonstrates the development of 




5 METABOLIC IMAGING OF CELL DEATH DYNAMICS 
5.1 Introduction 
As was shown in the previous chapter, the development of a high-speed 2P-FLIM system presents 
a major speed advantage over traditional, highly sensitive techniques for FLIM imaging based on 
TCSPC techniques [116]. Furthermore, these capabilities make the technology a unique tool 
specifically for tracking the early dynamics in apoptosis as has been discussed throughout this 
thesis and was shown briefly in Chapter 4. However, the role of these early NADH lifetime 
dynamics and the effects of various metabolic perturbations on these dynamics are of critical 
importance in understanding the relationship between metabolism and apoptosis induction at the 
cellular level. In this chapter, the previously developed high-speed 2P-FLIM imaging system is 
used to characterize these rapid metabolic dynamics in response to apoptotic stimuli under a wide 
range of conditions to study important effects such as the dose-dependent dynamics, the response 
of malignant vs. nonmalignant cells, and the metabolic response of apoptosis-resistant cells. 
Furthermore, high-throughput imaging of large fields-of-view, typically impractical using 
TCSPC-based techniques, is demonstrated for monitoring the heterogeneous response to cell-
death-inducing stimuli. Through these studies, the capabilities of this high-speed metabolic 
imaging platform are further demonstrated in order to further investigate the complex role of 
metabolism in cell death. 
5.2 Combined video-rate and longitudinal imaging of STS-induced apoptosis 
To first demonstrate the capabilities of this high-throughput imaging platform, MCF-7 breast 
cancer cells were imaged during the addition of STS as detailed in Chapter 4. Video-rate 2P-FLIM 
imaging was performed by rapidly acquiring datasets at 20 FPS and streaming this data directly to 
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the high-speed SSD in the acquisition PC. Datasets were acquired at 256x256 pixel image size 
with a temporal sampling rate of the lifetime decay curve of 0.625 ns. A dwell time of 
approximately 0.25 µs was utilized. Figure 5.1a-c shows snapshots from video acquisitions over 2 
minutes of cells treated with 1 µM STS.  
 
Figure 5.1 Longitudinal imaging of apoptosis induction in MCF-7 cells treated with 1 µM STS. (a-c) Short-term 
imaging of the same FOV (a) before and (b) 20 seconds, and (c) 120 seconds following treatment. (d) Longitudinal 
trace of the average lifetime across cells in the FOV from (a-c). (e-g) Imaging of the same FOV as (a-c) at timepoints 
of (e) 15 minutes, (f) 30 minutes, and (g) 45 minutes. Further imaging at (h) 2 hours and (i) 12 hours was performed 
in order to track long-term changes in NADH lifetime. (j) Long-term dynamics of apoptosis induction at time points 
up to 12 hours. Scalebar is 50 µm. 
As observed previously, this high-speed microscope can capture the rapid increase in NADH 
fluorescence lifetime within cells in direct response to this apoptotic stimulus as shown in Figure 
5.1d. In order to correlate these short-term dynamics with the long-term metabolic effects of 
apoptosis induction via STS, longitudinal imaging up to 12 hours of these same cells was 
performed at 15 minutes, 30 minutes, 45 minutes, 2 hours, and 12 hours (Figure 5.1e-j 
respectively). Analysis of cellular NADH lifetime levels shows a sharp increase following addition 
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of 1 µM STS that reaches a peak value after 2 hours and persists at this level at 12 hours. It is 
important to note that the images shown here exhibit greater variance of the lifetime signal within 
cells. This is likely due to the use of decreased excitation power causing a decrease in the SNR of 
the acquired decay curves. This ultimately can result in more uncertainty in the fitted lifetime value 
causing the observed intracellular variance of the lifetime value.  
These results detail the connections between the short-term and long-term dynamics associated 
with apoptosis induction in MCF-7 cells through STS treatment. Metabolic dynamics can be 
observed to occur rapidly upon treatment indicating dramatic increases in rates of aerobic 
metabolism within seconds of STS treatment. Interestingly, these initiation dynamics, occurring 
within seconds, are observed to exhibit the greatest rate of change in fluorescence lifetime over 
the course of the experiment, suggesting that STS treatment evokes an immediate increase in 
aerobic metabolism that will continue to grow until some steady-state “ceiling” is reached. This 
observed steady-state maximum lifetime presents an interesting future opportunity to investigate 
the metabolic requirements for apoptosis and to further understand whether this metric is 
associated with a saturation effect of NADH binding or represents a well-controlled equilibrium 
state of increased cellular metabolism necessary for apoptosis. 
5.3 High-throughput screening of cell death 
Next, in order to demonstrate the capabilities of this high-throughput imaging system for analyzing 
large cellular populations, large FOV imaging of cellular metabolic response to STS treatment was 
performed. To obtain a large FOV image of the specimen under investigation, a mosaicing 
procedure was performed using a motorized translation stage, averaging 20 frames recorded at 20 
FPS at each stage position, and stitching together the frames during post-processing. For all 
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datasets in this manuscript, 10-by-10 mosaics were acquired over an area of approximately 1.8 
mm x 1.8 mm in order to analyze large numbers of cells using the high-speed 2P-FLIM system. 
 
Figure 5.2 Wide FOV imaging of STS-induced apoptosis induction in MCF-7 cells. (a, b) Wide FOV images across 
an approximately 1.8 mm x 1.8 mm FOV (a) before and (b) 15 minutes following 1 µM STS treatment. (c, d) Zoomed 
views from the mosaics in (a) and (d) respectively. (e) Histogram of NADH lifetime values from pixels in cellular 
regions before (red) and 15 minutes following treatment (green). The histogram shows an increase in the mean NADH 
lifetime value across analyzed cells as well as a broadened distribution following treatment. (f) Results from 
AlamarBlue analysis of these cell cultures before treatment and immediately after treatment, demonstrating a large 
relative increase in oxidative phosphorylation in treated cells shortly after treatment. Scale bar is 200 µm in (b) and 
50 µm in (d). 
Figure 5.2 shows large FOV images of in vitro MCF-7 cells that were acquired before (Figure 
5.2a, zoomed region in Figure 5.2c) and 15 minutes after treatment with 1 µM STS (Figure 5.2b, 
zoomed region in Figure 5.2d), each requiring approximately 2 minutes total per acquisition, a 
huge improvement in speed compared to TCSPC, which may require several hours for a 
comparable FOV.  
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From this acquisition strategy, both metabolism and morphological features of large cellular 
populations can be screened in a relatively short period of time. Results here show the dramatic 
increase in NADH lifetime as has been observed previously (Figure 5.1) while population analysis 
(Figure 5.2e) clearly shows a noticeable increase in both the mean and variance of the NADH 
lifetime following STS treatment associated with the increased lifetime and heterogeneous 
response of cells to treatment.  
Additionally, in order to validate the results of this imaging, alamarBlue, a metabolic assay 
typically utilized for cell death quantification was utilized in this study [117]. This assay has been 
demonstrated previously to be sensitive to changes in mitochondrial metabolism, capable of 
validating these 2P-FLIM imaging results [118]. The assay was performed as part of this high-
throughput imaging experiment as follows: 24 hours following seeding of MCF7 cells at a density 
of 250k cells/mL into 35mm diameter plates, the alamarBlue (ThermoFisher) assay was performed 
according to manufacturer instructions. Media was removed from the cells and 2 mL of a solution 
of 90% (vol) media and 10% (vol) alamarBlue was applied. Cells were incubated with the 
alamarBlue and media solution for 1.5 hours. After the incubation, the alamarBlue solution was 
removed from the cells and replaced with the standard media. 2P-FLIM imaging was immediately 
performed of the dishes as shown in Figure 5.2a. Next, the cells were treated with 1 µM STS as 
described above. After 15 minutes, 2P-FLIM imaging was again performed of the dishes as shown 
in Figure 5.2b. Immediately following imaging, the alamarBlue protocol was repeated again 
applying 2 mL of a solution of 90% (vol) media and 10% (vol) alamarBlue to the cells and 
incubating for 1.5 hours before removing the solution. The alamarBlue and media solution was 
read in triplicate using a plate reader (BioTek) to measure absorbance at 570 and 600 nm, 
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additionally utilizing a media-only blank and an AlamarBlue/media blank. The relative metabolic 
rate was calculated using the absorbance values.  
The results of this alamarBlue assay show a large relative increase in the metabolism of treated 
cells compared to untreated cells (Figure 5.2f), suggesting that the observed changes in lifetime 
are due to increased NADH binding to the mitochondria associated with increased levels of aerobic 
metabolism, further providing a correlation between the 2P-FLIM contrast in our images and the 
mean lifetime metric of typical TCSPC-based 2P-FLIM systems. This approach also highlights 
the approach of combining high-throughput metabolic imaging with high-throughput molecular 
assays. While assays such as alamarBlue staining are highly sensitive to metabolism and rates of 
cell death, they are typically utilized to assess these parameters across an entire plate of cells, 
providing little insight into the spatial component of the heterogeneous cellular response. 
However, through the combination of high-speed imaging approaches such as the one employed 
here, the combination of cellular-level imaging resolution with molecular sensitivity can be used 
for future validation of 2P-FLIM imaging observations as well as in high-content screening 
approaches to study large populations of cells with both high resolution and molecular sensitivity. 
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5.4 Dose response of NADH lifetime dynamics 
Previous NADH 2P-FLIM studies of STS-induced apoptosis have noted a significant alteration of 
the longitudinal NADH lifetime dynamics of HeLa cells treated with low (50 nM) and high (1 µM) 
doses of STS, with larger STS concentrations showing more rapid and dramatic increases in mean 
lifetime [20]. In order to assess and better characterize the dose-dependent early metabolic 
dynamics of STS-induced apoptosis in MCF-7 cells, treatments of 500 nM (Figure 5.3a-c), 1 µM 
(Figure 5.3d-f), and 3 µM (Figure 5.3g-i) were introduced while imaging with the high-speed 2P-
FLIM microscope. NADH fluorescence lifetime dynamics from individual cells are shown in 
Figure 5.3j. From these plots, a rapid increase in fluorescence lifetime can be observed within 
seconds after the addition of STS for all doses utilized here. Additionally, this effect appears to be 
strongly correlated with the STS treatment concentration.  
 
Figure 5.3 Dose-dependent dynamics of NADH lifetime in MCF-7 cells treated with STS. (a-i) Snapshots of MCF-7 
cells at (a, d, g) 0 seconds, (b, e, h) 20 seconds, and (c, f, i) 120 seconds following treatment with (a-c) 500 nM, (d-f), 
1 µM, and (g-i) 3 µM STS. (k) Short-term dynamics plotted as the average lifetime across multiple cells in the FOV 
show a stronger initial increase with larger STS doses that persists at 2 minutes following treatment. Cells treated with 
1 µM and 3 µM STS show a statistically significantly increased NADH lifetime at 20 seconds and 120 seconds 
compared to the untreated group. Scale bar is 25 µm. *p<0.01. 
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At higher concentrations a rapid increase in lifetime is observed, indicating rapid increases in 
metabolism, more specifically in rates of oxidative phosphorylation. Statistical analysis for all 
comparisons was performed via one-way ANOVA followed by Tukey’s post-hoc test to make 
comparisons across the apoptosis, necrosis, and control cells. Data are presented in all cases as 
mean ± standard error. This analysis shows a statistically significant increase in the NADH lifetime 
observed in MCF-7 cells treated with 1 µM and 3 µM STS compared to untreated cells at 20 
seconds and 120 seconds (Figure 5.3k). In addition to this, a statistically significant increase in 
NADH lifetime was observed in the 3 µM STS treatment group compared to the 1 µM STS-treated 
group. This shows the capability and sensitivity of this high-speed FLIM approach to observe these 
potentially subtle, dose-dependent metabolic responses.  
These results suggest that by increasing the dose of STS applied to MCF-7 cells in vitro, a larger, 
more rapid increase in aerobic metabolism is induced, as has been suggested by previous studies 
investigating the longer-term effects of STS treatment on NADH fluorescence lifetime [20]. From 
our previous results, this implies that with larger STS dose, there is a more rapid, dramatic shift 
towards increased rates of oxidative phosphorylation. These differences in metabolic rate may be 
attributed to the effect of STS dose on the rate of cell-death related events in the cell. Previous 
studies comparing small and large doses of STS-induced apoptosis in HeLa cells have observed a 
significantly slower rate of caspase-3 activation and a delay in the formation of mitochondrial 
membrane pores in cells treated with lower STS doses that appear correlated with these NADH 
dynamics [20]. Accordingly, metabolic rates, including the initial transient dynamics observed 
here, may be directly related to the rate of activation of apoptosis-specific processes in response 
to the applied stimulus. Thus, this high-speed imaging platform constitutes a sensitive technique 
to potentially probe the metabolic processes and rates associated with apoptosis induction. 
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5.5 Apoptosis-related metabolic dynamics in cancer and non-tumorigenic cell lines 
In order to next determine the role that a cell’s baseline metabolic state has upon the early-stage 
initiation of metabolic dynamics following treatment with STS, non-tumorigenic (MCF10-A, 
Figure 5.4a-b), noninvasive cancer (MCF-7, Figure 5.4c-d), and invasive cancer (MDA-MB-231, 
Figure 5.4e-f) cell lines were imaged in response to 1 µM STS treatment. MCF-7 cells were 
cultured as mentioned previously in MEM alpha supplemented with 10% fetal bovine serum (FBS) 
and 1x antibiotics. MDA-MB-231 cells were cultured in Leibovitz’s L15 medium supplemented 
with 10% FBS and 1x antibiotics. MCF 10A cells were cultured in basal media (Lifeline 
MammaryLife Basal Medium).  
 
Figure 5.4 Comparison of malignant and non-malignant cellular NADH lifetime response to 1 µM STS. 2P-FLIM 
images of (a, c) MCF10-A, (c, d), and (e, f) MDA-MB-231 at time points of (a, c, e) 0 seconds and (b, d, f) 120 
seconds following treatment with 1 µM ST. (g) Statistical analysis of analyzed cells shows a statistically significant 
increase in the NADH lifetime increase over the course of imaging in MCF10-A cells compared to both MCF-7 and 
MDA-MB-231 cells. Scale bar is 50 µm. * p<0.01. 
All cells were cultured at 37˚C with 5% CO2, except for MDA-MB-231 cells which were cultured 
at 37˚C without CO2. Images at 0 and 120 seconds show the familiar NADH lifetime increase in 
all cell lines. However, the non-tumorigenic MCF-10A cell line showed a statistically significant 
(p < 0.01) increase in NADH lifetime response after 120 seconds compared to the two cancer cell 
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lines using the same analysis methods of the previous section. This implies that the non-
tumorigenic cell line may have greater aerobic respiration capabilities in order to respond to the 
STS stimulus at shorter time points compared to the other two cancer cell lines which have been 
characterized previously to have altered metabolic profiles in the case of MDA-MB-231 [111], or 
may be missing key pro-apoptotic proteins such as caspase 3 in the case of MCF-7  [119]. 
These observations have important consequences for future high-throughput screening 
applications. Most importantly, this unique imaging technique provides an interesting approach to 
potentially probe the metabolic capacity and response of different cellular conditions to an 
apoptotic stimulus. The results here compare favorably to previous studies demonstrating that the 
IC50 (concentration of compound resulting in 50% reduction in cell growth rate) for MCF-10A 
cells is at least an order of magnitude smaller than both MCF-7 and MDA-MB-231 [120]. This 
suggests further that there may be a correlation between cellular sensitivity to apoptosis-inducing 
compounds and the initiation dynamics observed from our high-speed 2P-FLIM imaging results. 
Further study, potentially combining screening tools such as the alamarBlue assay as shown in 
Section 5.3, should be used to further validate this observation and determine the accuracy of a 
screening approach based on NADH fluorescence lifetime dynamics. 
5.6 Metabolic dynamics of apoptosis-resistant cells 
Finally, in order to better use this tool to study conditions of inhibited cell death induction, the 
metabolic dynamics of a genetically modified apoptosis-resistant cell line (BAX-BAK double 
knock out (DKO) SV40 mouse embryonic fibroblasts; ATCC CRL-2913) were compared to their 
non-resistant counterpart (SV40 mouse embryonic fibroblast wild type (WT); ATCC CRL-2907) 
following treatment with 1 µM STS. High-speed 2P-FLIM imaging results are shown in Figure 
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5.5. These DKO cells are missing BAX and BAK, two key pro-apoptotic molecules necessary for 
mitochondrial-mediated apoptosis [121]. To begin, high-speed imaging was performed for the first 
2 minutes while WT (Figure 5a-d) or DKO cells (Figure 5e-h) were treated with 1 µM STS. 
Snapshots of the NADH lifetime are shown at 0 seconds (Figure 5a and 5e), 20 seconds (Figure 
5.5b and Figure 5.5f), 120 seconds (Figure 5.5c and Figure 5.5g), and 15 minutes (Figure 5.5d and 
Figure 5.5h).  
 
Figure 5.5 Analysis of NADH lifetime dynamics in BAX/BAK DKO apoptosis-resistant cell line. (a-h) Snapshots of 
(a-d) WT (non-resistant) and (e-h) BAX/BAK DKO cells at (a, e) 0 seconds, (b, f) 20 seconds, (c, g) 120 seconds, and 
(d, h) 15 minutes following 1 µM STS treatment. (i) Short-term tracking of NADH lifetime dynamics reveals a 
statistically significant increase in the NADH lifetime of WT cells compared to DKO cells at approximately 120 
seconds following treatment (p<0.01). (j) NADH lifetime at later times (up to 48 hours) reveals comparable NADH 
lifetime values between WT and DKO cells. Scale bar is 50 µm. 
Comparing the two conditions, the WT cells had a statistically significantly increased lifetime 
compared to DKO cells at 2 minutes following treatment (Figure 5.5i) following previous 
statistical analysis methods. Imaging was again performed at 24 hours and 48 hours following 
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treatment (Figure 5.5j). Interestingly, the NADH lifetimes at these time points were all quite 
comparable, suggesting that the metabolic dynamics between the resistant and non-resistant cells 
differ only in the earliest initiation stages of apoptosis.  
In order to determine the extent of apoptosis in the cultures following STS treatment, brightfield 
fluorescence imaging was performed using a cleaved caspase 3/7 assay (ThermoFisher CellEvent) 
and a propidium iodide (PI) assay (ThermoFisher). Increased levels of cleaved caspase 3 and 7 are 
strongly associated with apoptosis and are commonly used to assess levels of apoptosis in vitro 
[122]. Similarly, PI is commonly used as a cell-death-specific stain [123]. Apoptotic cell death 
was confirmed in the WT cells 24 hours after treatment (Figure 5.6) through widefield fluorescence 
imaging of a cleaved caspase 3/7 marker (ThermoFisher CellEvent), while nearly no cell death 
was observed in the apoptosis-resistant DKO cell line at 24 or 48 hours (Figure 5.6 and Figure 
5.7). It has been previously reported that these DKO cells will undergo autophagy, a natural 
regulatory mechanism of cells to remove unwanted or dysfunctional organelles, in order to survive 
the apoptotic stimulus [124], which was confirmed through brightfield microscopy of an 
autophagy flux stain in these cells after 48 hours as shown in Figure 5.8. These results suggest that 
while many of the later stage metabolic trends of STS treatment in resistant and non-resistant cells 
may be similar, the differences in the early dynamics may elucidate some of the dysfunctional 





Figure 5.6 Cleaved-caspase 3/7 analysis of WT and DKO cells untreated and treated with 1 µM STS. WT cells treated 
with STS show a strong increase in cleaved caspase 3/7 marker staining implying increased rates of apoptosis, while 
DKO cells show little to no cleaved caspase 3/7 marker signal. 
 
Figure 5.7 PI staining at 48 hours of same treatment conditions in Figure 5.6 shows that although DKO treated cells 
show clear morphological changes 48 hours following STS treatment, they show no signs of membrane permeability 
suggesting DKO cells are still viable at this time point. 
Interestingly, BAX activation and translocation from the cytoplasm to the mitochondria is 
established to occur within 30 minutes of STS treatment [125], and these alterations in early 
metabolic dynamics observed in DKO cells may be associated with the absence of BAX and the 
mitochondrial interactions that occur following STS treatment in WT cells. Thus, high-speed 2P-
FLIM imaging of NADH may provide a unique window to observe these dysfunctional metabolic 
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pathways that may only show clear distinguishing features at the early initiation stages of apoptosis 
induction. 
 
Figure 5.8 Autophagy flux staining at 48 hours in STS treated WT and DKO cells. STS treated DKO cells show an 
increase in autophagic flux compared to WT and untreated DKO cells 48 hours following treatment with 1 µM STS. 
The role of metabolism in cell survival and the dependence of DKO cells on autophagy merit 
further study. While clear morphological alterations can be observed in autophagic, STS-treated 
DKO cells at 24 and 48 hours following treatment (Figure 5.6 and Figure 5.7), the NADH lifetime 
is observed to be quite similar between treated DKO and WT cells at these time points. This 
suggests that the increased oxidative metabolism elicited by the introduction of STS may drive 
apoptosis in the case of WT cells and autophagy in the case of DKO cells, but that the preferred 
pathway is likely determined by intracellular factors including cell death-associated proteins 
within cells such as BAX and BAK. Interestingly, the relationship between autophagy and NADH 
fluorescence lifetime imaging has not yet been fully explored. While there is a well-established 
connection between the culture of cells under starvation conditions, known to decrease 
intracellular NADH levels, and the presence of autophagy [126], the role that autophagy may play 
 84 
  
in apoptosis resistance as well as the associated NADH fluorescence dynamics is an important area 
of future research. 
5.7 Conclusions 
The high-throughput metabolic imaging platform presented here has been shown to provide unique 
insight into the dynamic and heterogeneous metabolic effects of STS-induced apoptosis in a 
variety of conditions. Through the study of longitudinal short-term dynamics and their dose-
response, as well as the metabolic effects across a large population of cells, the role of metabolism 
in apoptosis has been probed with this microscope in cells with differing metabolic profiles as well 
as in genetically resistant cells. While the strong link between metabolism and cell death has been 
shown here, further study combining this approach with standard high-throughput metabolic and 
cell health assays should be performed in order to better understand the precise mechanism 
responsible for the observed metabolic dynamics. In addition, further high-speed 2P-FLIM 
imaging of the cellular effects of clinically relevant cell-death-inducing agents should be 
undertaken in order to assess the utility of this technique as a clinical screening tool as has been 
suggested by several optical metabolic imaging studies [14, 16]. Through further development, 
this promising imaging approach may provide a powerful tool for both scientists and clinicians to 




6 HIGH-SPEED METABOLIC IMAGING OF NEURONAL ACTIVITY 
6.1 Motivation 
Previous chapters have demonstrated the capabilities of the developed high-speed 2P-FLIM 
system for imaging transient metabolic dynamics, especially in the case of studying the early 
response to apoptosis-inducing stimuli. However, this technology has the potential to enable study 
of a much wider range of dynamic biological phenomena. In particular, the study of cellular-level 
metabolic dynamics in the brain presents a strong application of this technology. 
The brain is an incredibly dynamic system. Action potentials in neurons occur on the order of 
milliseconds and require a large quantity of energy for sustained activity. While functional whole-
brain imaging has revealed strong indications of increased levels of glycolysis in the brain 
following stimulation [87], the cellular basis of these dynamics has been fiercely debated for 
decades, with little direct evidence. The primary question centers on the metabolic role of glial 
cells, specifically astrocytes, in the brain. Many studies have provided strong evidence that these 
astrocytes support neurons through increased rates of glycolysis in order to provide lactate, a 
substrate for oxidative phosphorylation, to neurons as described by the ANLS hypothesis. This has 
come in the form of evidence of increased levels of aerobic glycolysis and lactate production 
following glutamate uptake in vitro in astrocyte cultures [127] as well as several in vivo studies 
using [18FDG] PET and MRS demonstrating that lactate can serve as a primary substrate for 
neuronal oxidation [128, 129]. More recently, however, evidence has been presented that seems to 
refute this hypothesis [23, 130], conflicting with the results of NADH imaging studies [26]. This 
critical debate demonstrates the need for a fast, sensitive metabolic tool capable of studying neuron 
and astrocyte metabolism with high spatio-temporal resolution. 
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6.2 NADH and the ANLS hypothesis 
In order to understand how NADH imaging be used to answer this open question, it is first 
important to understand the central role of NADH under the assumption of the proposed ANLS 
hypothesis. Under the theory, sustained energy is provided specifically through the preferential 
consumption of glucose by astrocytes, producing lactate as an end-product that is shuttled to 
neurons where it may be oxidized to generate ATP. NADH transients following electrical or 
chemical stimulation in brain slices have long been used to assess this theory but have shown 
evidence that both supports [26] and discredits [86] the theory. In 2004, Kasischke et al. provided 
the first direct evidence of spatial and temporal segmentation of these signals using high-resolution 
2PF NADH microscopy as shown in Figure 6.1 [26]. The authors of this critical study propose that 
the spatially and temporally segregated NADH transients represent rapid neuronal oxidative 
phosphorylation, leading to the rapid decrease of NADH fluorescence observed, followed by an 
increase in astrocytic glycolysis, observed as the spatially distinct, long-lived increase in NADH 
fluorescence. While these results provided strong evidence in favor of the ANLS hypothesis, the 
theory has recently been called into question after results provided by extremely detailed study of 
NADH transients [86], as well as the use of custom-designed redox probes [23], which 
demonstrate both a significant presence of neuronal glycolysis and a limited role of lactate 
oxidation following stimulation. Both studies call into question the images shown in Figure 6.1 as 




Figure 6.1 2PF NADH imaging of metabolic activity following neuronal activation. (a) Measured NADH response 
averaged across a large FOV representing both the “dip” and “overshoot” phases of the biphasic NADH response to 
stimulation. (b) and (c) show images of the spatial locations of the temporally separated “dip” and “overshoot” phases 
respectively. (d) Overlay of the “dip” and “overshoot” regions showing that these spatial regions tend to be spatially 
segregated, suggesting isolated regions of neuronal oxidative phosphorylation and astrocytic glycolysis. From [26]. 
Reprinted with permission from AAAS. 
In addition, it is important to note that using NADH fluorescence emission as a marker of relative 
levels of oxidative phosphorylation and glycolysis can be misleading due to several factors. First, 
the oxidative phosphorylation process relies directly on the products of glycolysis and thus 
increases in levels of oxidative phosphorylation must also be met with appropriate increases in 
glycolysis levels in order to sustain efficient ATP production. Furthermore, the binding status of 
NADH is an important factor that is not often considered when using NADH fluorescence intensity 
to assess metabolic state. NADH, when bound to mitochondria, exhibits a strongly increased 
fluorescence emission and is quenched when unbound in the cytoplasm [21]. As a specific example 
of this, 2PF and 2P-FLIM imaging of apoptosis induction shown in Chapter 4 of this thesis 
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demonstrated that upon treatment, NADH fluorescence emission will strongly increase and is 
actually associated with relative increases in oxidative phosphorylation rates as seen in Figure 4.8.  
This discussion motivates the need for further high-resolution, high-contrast imaging of this 
dynamic microenvironment with the fast 2P-FLIM platform developed in Chapter 4. This system 
can provide high spatial and temporal resolution and is specifically sensitive to the binding state 
of NADH, allowing direct assessment of relative levels of oxidative phosphorylation and 
glycolysis in order to further explore the cellular basis and metabolic implications of these transient 
signals. 
6.3 Multimodal imaging of neuronal and metabolic dynamics 
In order to further study these dynamic NADH transients, the high-speed 2P-FLIM system was 
modified to enable 2PF imaging at 920 nm in order to image GCaMP6s-labeled mouse 
hippocampal cultures. GCaMP6s, an intracellular label used to track calcium dynamics, has been 
shown to be a highly correlated marker for neuronal firing and will be used here to spatially 
correlate the metabolic signatures obtained via 2P-FLIM imaging with areas of actively firing 
neurons [131].  
Hippocampal cultures were prepared as follows: mouse hippocampi were isolated from P2-P3 
transgenic mice (C57BL/6J-Tg(Thy1-GCaMP6s)GP4.12Dkim/J, Jackson Labs), and either used 
immediately for culturing, or stored on ice in Hibernate-A (HA, BrainBits) at 4º C for one day, 
and used the following day for culture. All procedures were carried out in a certified biological 
safety cabinet (BSC). The hippocampal tissue was brought into the BSC and rinsed twice with 10 
mL of HA, and subsequently agitated with a HA-Calcium/papain (0.5 mL/mg) mixture in DI water, 
pre-incubated at 37º C, for 25 minutes. Thereafter, the tissue was mechanically dissociated by 
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withdrawal twice with a 20 G needle attached to a 20 mL syringe. This was repeated once more 
with a 22G needle. The dissociated cells were then filtered using a 20 μm filter and centrifuged at 
2000 rpm for 6 minutes. The supernatant was then vacuumed, and the cells suspended in 500 µL 
of DMEM (Dulbecco’s Modified Eagle Medium). Upon suspension, the cells were counted using 
a hemocytometer, and plated onto glass-bottom 35 mm culture dishes (Mat-Tek) to a final density 
of 200,000 cells per dish, ensuring the 200,000 cells were planted in 40 µL of DMEM. These cells 
were then placed in a cell culture incubator (5% CO2, 37 º C) for an hour. Finally, 500 µL of pre-
incubated DMEM and 1 mL of NBActive4 were added to the culture. Cultures were grown to DIV 
10+, and media changed with NBActive4 every 3-4 days, until imaging was performed. These 
primary cultures contain a mix of neurons and glia, and have been well established as a model for 
investigating cellular level behavior of the active, living brain [132]. 
In order to demonstrate the capabilities of this multimodal approach for imaging, Figure 6.2 shows 
a representative dataset from these GCaMP6s-labeled hippocampal cultures combining 2PF and 
2P-FLIM imaging of NADH with calcium imaging of spontaneous neuronal activity. Imaging is 
performed by first collecting data at an excitation of 920 nm in order to excite GCaMP fluorescence 
as shown in Figure 6.2b. Following this, the excitation wavelength is tuned down to 750 nm for 
NADH 2PF and 2P-FLIM imaging (Figure 6.2a and d). This imaging approach permits specific 
identification of neurons, labeled by GCaMP, in NADH 2PF and 2P-FLIM imaging as seen by the 
overlay of Figure 6.2c, which has proved difficult in the past due to the high tissue density, large 
NADH fluorescence signal from the background neuropil, and the relatively low NADH 
fluorescence that can be observed from neurons as seen in Figure 6.2a-c (white arrow). Results 
from this imaging show an agreement with previous reports of 2PF imaging in brain slices, where 
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large NADH fluorescence emission is observed from surrounding glial cells, found to be 
astrocytes, while a relatively weak NADH signal is observed in neurons. 
  
Figure 6.2 Multimodal GCaMP 2PF and NADH 2P-FLIM imaging of spontaneous activity in dissociated mouse 
hippocampal cultures. Images of (a) 2PF NADH intensity, (b) GCaMP6s, and (d) 2P-FLIM of NADH allow combined 
detection of neurons and neuronal activity with metabolic imaging. (c) Overlay of the 2PF NADH and GCaMP 
channels provides specific identification of NADH neuronal features, such as the lower fluorescence emission from 
this region compared to neighboring glial cells. Scale bar is 50 µm 
Interestingly, 2P-FLIM imaging shows a somewhat homogeneous lifetime across both neurons 
and surrounding astrocytes, while it is expected that astrocytes will be more glycolytic than 
neurons under baseline conditions. The observations here could be influenced by a few important 
factors. First, the NADH signature from the neuron is quite weak, which may lead to the 
acquisition of a lower SNR decay curve. Additionally, these samples are extremely dense and have 
several layers. As the axial resolution of 2P-FLIM is considerably lower than the transverse 
 91 
  
resolution, it is possible that background fluorescence from other cells at different layers may be 
contributing to the observed lifetime. 
6.4 2P-FLIM NADH imaging of neuronal activation upon stimulation 
Next, this multimodal approach was utilized to study metabolic interactions within these cultures 
following stimulation. Stimulation was applied to cultures through introduction of glutamate, an 
important neurotransmitter, which was added to the cultures resulting in a final concentration of 
100 µM. 2PF results obtained from imaging of NADH and GCaMP are shown in Figure 6.3. Prior 
to stimulation, 2PF GCaMP imaging was utilized to find a region exhibiting some amount of 
spontaneous activity (Figure 6.3d). This region was then utilized for dynamic 2PF and 2P-FLIM 
imaging at 20 FPS for 2 minutes during glutamate treatment. For display and analysis, 2PF NADH 
images were acquired from averaged frames over 5 seconds in order to improve the SNR. Figure 
6.3a-b shows images before (Figure 6.3a) and 2 minutes following (Figure 6.3b) the addition of 
glutamate. From these images a sharp decrease in NADH fluorescence emission can be observed 
from a subpopulation of cells within the field of view (Figure 6.3a-b red arrow). The fluorescence 
intensity of other cells was observed to slightly increase over the duration of the imaging (Figure 
6.3a-b blue arrow). To assess the spatial confinement of these transient NADH fluorescence 
dynamics, a difference image was constructed by subtracting the image of Figure 6.3b from Figure 
6.3a and is shown in Figure 6.3c. This image shows a strong spatial confinement of this NADH 
decrease within cells that are colocalized with the spatial locations of several active neurons 
identified through GCaMP imaging (Figure 6.3d red arrow). Longitudinal plots from these images 
(Figure 6.3e) demonstrate a distinct “dip” phase associated with neurons (Figure 6.3f) and an 
“overshoot” phase associated with astrocytes (Figure 6.3g), providing strong evidence of a cellular 




Figure 6.3 Multimodal 2PF NADH and GCaMP imaging of hippocampal cultures following 100 µM glutamate 
stimulation. (a) and (b) NADH 2PF images (a) before and (b) 2 minutes after stimulation, show a cellular dependence 
in the response leading to the sharp fluorescence decrease in some cells, compared to slight fluorescence increase in 
others. (c) The difference image obtained by subtracting the image in (b) from the image in (a) shows that this sharp 
decrease exists in only a subpopulation of cells in the field-of-view. (d) GCaMP imaging of the same region before 
stimulation confirms that these cells which exhibit the sharp NADH decrease following stimulation are indeed 
neurons. Red arrow corresponds to identified neuron and blue arrow corresponds to cell identified as astrocyte. (e) 
Longitudinal plot of NADH response to stimulation across the entire FOV. (f) Longitudinal plot of NADH response 
in neurons. (g) Longitudinal plot of NADH response in individual astrocytes. Scale bar is 50 µm. 
From Figure 6.3f and g, large variations in cellular response can be observed. In neurons, this may 
be reflective of the heterogeneity in either the initial or post-activation metabolic state across the 
cellular population. Importantly, the representative “dip” phase is observed in each cell, with no 
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strong “overshoot” pattern. In cells identified here as astrocytes, a more heterogeneous response 
is seen, where some cells exhibit the delayed “overshoot” phase, some appear to exhibit a “dip” 
and “overshoot” phase, and a few cells exhibit no noticeable change whatsoever. This may be 
reflective of the spatial positions of these cells and the demands of nearby neurons. Additionally, 
while we assume that the majority of these cells are astrocytes due to the strong NADH 
fluorescence, different responses may be due to smaller populations of other glial cells such as 
microglia or oligodendrocytes. 
In order to further understand the metabolic processes responsible for these NADH transients, 2P-
FLIM analysis was performed on these datasets as shown in Figure 6.4. The low SNR of the 
acquired datasets results in somewhat noisy 2P-FLIM images, but some important trends can be 
observed. Figure 6.4a-c shows images acquired before stimulation, within 10 seconds immediately 
following stimulation, and 2 minutes post-stimulation respectively. In several cells identified as 
neurons, a sharp increase in the NADH lifetime can be seen immediately following stimulation 
(Figure 6.4d), providing further evidence that the observed “dip” phase is likely associated with 
neuronal oxidative phosphorylation as has been suggested previously [26]. However, due to the 
sharp decrease in NADH fluorescence emission, lifetime analysis at later time points becomes 




Figure 6.4 2P-FLIM imaging of hippocampal cultures following 100 µM glutamate stimulation. Images acquired (a) 
before, (b) within 10 seconds following stimulation, and (c) 2 minutes following stimulation show distinct metabolic 
dynamics in astrocytes (blue arrow) and neurons (red arrow). (d) Plots of lifetime dynamics in cells corresponding to 
red and blue arrows in (a-c). Due to the decreased NADH fluorescence level of neurons, the NADH lifetime cannot 
be accurately tracked past the initial “dip” phase. Scale bar is 50 µm. 
Analysis of cells identified as astrocytes also leads to noisy longitudinal NADH lifetime dynamics, 
but the general trend of a decrease followed by a recovery of the fluorescence lifetime can be 
observed, suggesting that immediately following stimulation, astrocytes may immediately exhibit 
an increase in glycolysis followed by a return to baseline, and potentially a shift towards increased 
oxidative phosphorylation approximately one minute after stimulation. In comparison to these 
results, Figure 6.5 gives results for the same experiment repeated with cultures incubated in 1 µM 





Figure 6.5 2PF and 2P-FLIM NADH imaging of TTX inhibition of neuronal activity during 100 µM glutamate 
stimulation. (a-b) 2PF NADH images (a) before and (b) 2 minutes following glutamate stimulation. (c-d) 2P-FLIM 
NADH images before and 2 minutes after glutamate stimulation. (e) Longitudinal plots of cellular NADH fluorescence 
from a representative neuron and astrocyte corresponding to the red and blue arrows respectively in (a-c). A small dip 
in the neuron and astrocyte NADH fluorescence signal is observed, but the overshoot signal observed in uninhibited 
stimulated cultures is not observed here. Scale bar is 50 µm. 
Longitudinal, high-speed imaging reveals a similar decrease in NADH intensity that is particularly 
noticeable in cells that have the previously reported fluorescence properties of neurons (Figure 
6.5a-b red arrow). However, the time-delayed increase in NADH fluorescence observed in Figure 
6.3 is not seen under these inhibited conditions, likely due to the TTX inhibition of neuronal 
activation (Figure 6.5e). Lifetime images, as shown in Figure 6.5c-d, show relatively little change 
over the course of the 2-minute acquisition. 
These results provide further insight into the cellular basis of energy production in the brain. While 
previous studies noted spatial segregation of the two components of the biphasic response, the lack 
of contrast and clear visualization of neurons and astrocytes as well their response to stimulation 
has limited acceptance of previous studies within the neuroscience community. Here, direct 
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evidence of the cellular basis of the neuronal “dip” and astrocyte “overshoot” phases is presented 
through high-speed 2PF imaging of the intrinsic NADH fluorescence response to glutamate 
stimulus in GCaMP-labeled mouse hippocampal cultures. Additionally, 2P-FLIM imaging 
provides further insight into the specific metabolic processes associated with these dynamics. The 
rapid decrease in neuronal NADH fluorescence is correlated with a corresponding increase in 
lifetime, suggesting an increase in relative rates of oxidative phosphorylation within neurons 
immediately following stimulation. The time-delayed “overshoot” phase associated with 
astrocytes was accompanied by a decrease in lifetime followed by a recovery and increase above 
baseline values after 2 minutes, suggesting an immediate increase in glycolysis rates followed by 
a shift towards oxidative phosphorylation. In contrast to this, TTX inhibition of neuronal activity 
seems to have the greatest effect on the “overshoot” phase within astrocytes. As neuronal firing 
will be quite limited under these conditions, the energy required will be substantially less and may 
not require the intervention of astrocyte metabolism.  
Together, these results combine to further validate previously suggested cellular metabolic roles 
in the brain. However, these results must be further reconciled with recent high-resolution imaging 
results suggesting a limited role of lactate metabolism within neurons. While it seems likely that 
the astrocyte-specific “overshoot” phase observed here is associated with an increase in lactate 
production, the role of lactate metabolism in neurons following stimulation requires further, 
detailed study. The previous observation of increased levels of glycolysis in neurons on the order 
of minutes following stimulation [23] provides evidence that there is likely a contribution from 
both neuronal glycolysis and astrocyte-generated lactate oxidation. The relative contributions of 




6.5 Large field-of-view imaging of metabolic activation 
One of the major difficulties associated with high-resolution optical imaging of neuronal activity 
is the limited FOV. This is typically necessary in many areas of brain research where neuronal 
dynamics must be observed across large brain regions, leading to the development of complex 
optical system design in order to accomplish simultaneous imaging at high speeds across large 
tissue regions [133]. To address this, a large FOV imaging approach was developed in order to 
demonstrate the capabilities of this multimodal imaging approach for profiling a large population 
of cells, useful for further understanding the important metabolic roles of neurons and glia 
following neuronal stimulation. Figure 6.6 demonstrates this large FOV imaging approach 
combining 2PF/2P-FLIM NADH and 2PF GCaMP imaging. Figure 6.6a-d provide co-registered 
overlays of the 2PF NADH (magenta) and GCaMP6s (green) signals before (Figure 6.6a) and 
approximately 5 minutes after (Figure 6.6b) 100 µM glutamate stimulation. Zoomed regions of 
these images (blue rectangle) in Figure 6.6c-d show clearly the increased GCaMP signal 
originating from neuronal activation (blue arrows), accompanied by the increased NADH 




Figure 6.6 Large FOV multimodal 2PF GCaMP and NADH imaging of neuronal activation and cellular metabolism. 
(a-d) overlaid 2PF imaging of NADH (magenta) and GCaMP (green) fluorescence images (a) before and (b) 
approximately 5 minutes following application of 100 µM glutamate. (c-d) show zoomed regions corresponding to 
the blue box in (a) and (b) respectively. Following stimulation, an increase in neuronal activity can be observed in 
several regions corresponding to the enhanced green fluorescence from GCaMP. Similarly, an increase in NADH 
fluorescence, mostly confined to astrocytes, can be clearly observed. Scale bar is 200 µm. 
Corresponding 2P-FLIM images before and after stimulation are shown in Figure 6.7a and Figure 
6.7b respectively. Figure 6.7c-d show zoomed regions highlighting interesting lifetime features, 
notably the presence of a long lifetime axon or dendrite (white arrows). While only a few of these 
processes are observed in these datasets, the long lifetime suggestive of increased rates of oxidative 
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phosphorylation is likely due to the abundance of mitochondria within many of these extensions 
[134].  
 
Figure 6.7 Large FOV 2P-FLIM imaging of neuronal activation corresponding to the images shown in Figure 6.6. (a-
b) 2P-FLIM images of neuronal cultures (a) before and (b) approximately 5 minutes after stimulation. (c-d) zoomed 
regions corresponding to the red box in (a) and (b) respectively. White arrows correspond to a highly oxidative axon 
or dendrite. Scale bar is 200 µm. 
Nearby, the NADH fluorescence emission in neighboring cells appears to increase following 
stimulation as well as to exhibit a decreased fluorescence lifetime, suggestive of increased 
glycolytic metabolism within astrocytes as observed previously in Section 6.4. These results 
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demonstrate the unique capability of this system to probe large FOVs, allowing tracking and 
profiling of both neuronal activity and metabolic cooperation across a large cellular population, 
providing a critical tool for the study of dynamic cellular metabolism in the brain. 
6.6 Conclusions 
Neuronal cultures and the living brain present challenging imaging conditions due to the incredibly 
dense tissue structure, large optical scattering, and decreased NADH fluorescence SNR compared 
to other tissues. While previous studies relied on the use of low-resolution, wide-field imaging or 
high-resolution, low-contrast imaging of NADH, the imaging system presented here is capable of 
dynamic imaging of neuronal cultures with high contrast and cellular-level resolution. Through 
combination of GCaMP6 and NADH autofluorescence, the developed high-speed metabolic 
imaging platform has been demonstrated to study the metabolism of neuronal activity at the 
cellular level with imaging rates capable of observing NADH transients occurring within seconds 
following stimulation. This system was utilized to confirm the cellular basis of the “dip” and 
“overshoot” phases associated respectively with neurons and astrocytes providing a level of 
additional support to the ANLS hypothesis. Additionally, large FOV imaging was demonstrated 
to probe the correlation between metabolic signatures and neuronal activity across large regions 
and cell populations. This approach represents a major step forward in the study of the cellular 
basis of energy production in the brain. Through further development of this technology, such as 
increasing the sensitivity of 2P-FLIM, this tool can be used to sensitively probe the energetic 
pathways of neurons and glia cells within the active brain, providing a powerful tool for the study 
of a still poorly understood and heavily debated metabolic system. 
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7 CONCLUSIONS AND OUTLOOK 
7.1  Summary 
The work presented in this thesis has explored and expanded the capabilities of cellular-level 
imaging of metabolic dynamics. Traditional TCSPC 2P-FLIM imaging was used to identify in vivo 
metabolic markers of cell death and motivated the need for a high-speed platform capable of 
imaging much faster than commercially available TCSPC-based microscopes. This high-speed 2P-
FLIM imaging platform was developed and constructed and was shown to be highly sensitive to 
metabolic dynamics when used for NADH imaging.  
With the new high-speed metabolic imaging platform, a deeper exploration into the early dynamics 
associated with programmed cell death was undertaken, leading to the discovery that these early 
dynamics are particularly important and very sensitive to factors such as the potency of the cell 
death stimulus and the potential sensitivity of the cell to undergo cell death. Finally, this unique 
system was brought to a new application and combined with labeled calcium imaging to study the 
controversial topic of the cellular metabolism of neural activity. Results provided further clarity 
that neurons and astrocytes do indeed play distinct roles in brain metabolism following stimulation, 
suggesting a cooperation between these two cell types in order to generate the necessary energy to 
support sustained neuronal activation. 
7.2 Future studies 
While this thesis has presented a major step forward for the study of dynamic metabolic 
microenvironments, there are many improvements that can be made to further the technology as 
well as many future directions that can be pursued that have previously not been tractable with 
currently available technology. 
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7.2.1 Improvements in high-speed 2P-FLIM imaging 
 
To begin, while the developed high-speed 2P-FLIM imaging approach presents a major step 
forward in probing the metabolic dynamics at the cellular level, many future improvements to the 
technology can be implemented to improve the quality of the obtained data. The two major 
limitations of this technique are the limited temporal resolution as well as the broad IRF of this 
system due to the speed of the digitizer and the PMT respectively. With this system design, the 
sampling of the decay curve is directly determined by the maximum speed of the digitizer, while 
the IRF is currently limited by the response time of the PMT. Recently, faster digitizers have been 
developed that are currently approaching 10 GS/s rates, which would start to bring the sampling 
rate closer to that of TCSPC [135]. Additionally, initial studies have been undertaken to replace 
the original PMT module used with a micro-channel plate PMT (MCP-PMT), which has a much 
faster response function [136] as shown in preliminary data collected from our high-speed 2P-
FLIM system in Figure 7.1. 
Similarly, spatial resolution is another parameter of the current imaging system that can be studied 
further. The current spatial resolution of this system is on the order of 100 µm. potentially allowing 
subcellular features to observed and further studied. However, the results of this work and the 
majority of cellular metabolic imaging studies have not yet exploited this advantage, usually 
restricting analysis to metabolic parameters averaged across single cells. This could provide insight 
into the intracellular metabolic heterogeneity as well as give a direct mapping of metabolic events 
in single cells. Additionally, the development of super-resolution optical imaging techniques can 
allow even higher-resolution imaging performance to be obtained. For example, localization 
microscopy techniques have recently been extended to endogenous fluorescence from deoxyribose 
nucleic acid (DNA), allowing autofluorescence imaging with resolution on the order of 20 
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nanometers [137]. Techniques such as this may be investigated further to study NADH and 
potentially enable direct study of NADH shuttling and binding to complex I at the mitochondria. 
Another important challenge facing the current imaging platform is the long data processing times 
and the large data burden due to the fast sampling and long duration of the imaging performed 
here. As has been proposed previously, this can be improved through the development of online 
processing techniques potentially implementing such a technique on the GPU of the acquisition 
PC as has been demonstrated by other researchers [63, 138]. Through online processing of the data 
on the GPU, the data throughput can be significantly decreased as much of the raw data can be 
discarded. This methodology would also decrease the amount of storage space necessary to store 
longitudinal video-rate datasets, such as those shown in Chapters 3-6 of this thesis, which can 
require 10-100 GB of storage space each, depending on the duration of imaging. 
Finally, the incorporation of additional imaging modalities into this high-speed imaging platform 
may allow further characterization of dynamic metabolic microenvironments. In particular, the use 
of exogenous fluorescent probes and spectral-based detection methods may provide a method for 
simultaneous imaging and validation of the acquired metabolic imaging results. While Chapter 6 
of this thesis presented a method for combined GCaMP and NADH fluorescence imaging, a 
stronger approach is to design experimental approaches that may allow simultaneous NADH 
fluorescence lifetime imaging and an additional fluorescence channel for validation. This approach 
would serve to better confirm many of the results described here that often are difficult to validate 




Figure 7.1 Comparison of the IRF of the PMT utilized for data acquisition in Chapters 4-6 and an MCP-PMT. The 
MCP-PMT has a much narrower IRF, which may result in greater accuracy and sensitivity to measure NADH lifetime 
dynamics. 
7.2.2 High-throughput in vivo tracking of apoptosis dynamics 
 
While the application of the developed high-speed 2P-FLIM microscope to in vitro imaging was 
shown, one of the major advantages of nonlinear imaging is the capability of performing relatively 
deep tissue imaging in vivo. Chapter 3 of this thesis demonstrated the capabilities of identifying 
and tracking apoptosis in single cells in vivo. The development of an in vivo imaging approach 
utilizing the developed high-speed 2P-FLIM system would allow the study of large regions of 
tissue and, most importantly, the heterogeneous therapeutic response in the tumor 
microenvironment.  
While not a part of the work in this thesis, this microscope has been independently utilized by 
other investigators to begin looking at the in vivo skin wound healing microenvironment, showing 
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the ability to image across a large cellular region encompassing almost entirely a 1 mm wound as 
shown in Figure 7.2 [139]. This highlights the ability to successfully translate this tool for in vivo 
imaging and presents an exciting direction to potentially enable cellular-level therapeutic 
monitoring in vivo, an important advance in the quest for personalized medicine. 
 
Figure 7.2 in vivo 2P-FLIM mosaic of the epidermal skin layers of a wounded mouse. The capability of this technique 
to image large FOVs allows imaging of nearly the entire wound bed, which is impractical with the traditional TCSPC-
based technology. Adapted from [139]. Scale bar is 200 µm. 
Additionally, the potential to move this technology and imaging approach into a clinical setting 
such as the operating room presents an exciting future direction. Similar nonlinear microscopy 
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techniques have found clinical application in settings such as dermatology [15] and pathology 
[140]. Similarly, within the Biophotonics Imaging Laboratory at the University of Illinois, the 
capabilities of both optical coherence tomography [141] and nonlinear label-free microscopy [142] 
have been demonstrated for clinical translation. The approach to implementing an intraoperative 
high-speed 2P-FLIM imaging system would look quite similar to the previously developed 
intraoperative nonlinear imaging system as shown in Figure 7.3. This approach could allow 
metabolic imaging and profiling of the tumor microenvironment, providing sensitive information 
regarding the tumor microenvironment based on the intrinsic NADH fluorescence of cells in order 
to assist surgeons in the safe removal of cancerous tissue. 
 
Figure 7.3  Biophotonics Imaging Laboratory cart-based nonlinear microscopy platform utilized for intraoperative 
imaging. A similar approach could be used to translate the developed 2P-FLIM imaging techniques for clinical 
applications. Figure adapted from [142]. 
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7.2.3 High-throughput imaging and screening of cancer therapeutic efficacy 
 
In addition to the applications of this approach to in vivo imaging, this technique has the potential 
to be a high-sensitivity in vitro tool for cancer therapeutic screening. Currently, many researchers 
are utilizing TCSPC-based 2P-FLIM imaging approaches to study the metabolism in primary 
tumor organoids in response to therapeutic treatment [14]. These studies have found that metabolic 
imaging is correlated with patient outcomes and can determine the presence of drug-resistant 
subpopulations of cells. However, the reliance of these approaches on TCSPC-based systems 
presents a major limitation for translating this technology to a screening platform where hundreds 
or even thousands of drugs and drug combinations can be assessed rapidly in order to quickly 
determine the best possible treatment options for a patient. The development of a high-speed 
screening platform, based on our high-speed 2P-FLIM system design, presents an opportunity to 
incorporate this highly sensitive technique to the current technology utilized by clinicians and 
researchers to determine therapeutic efficacy in vitro. 
7.2.4 Metabolic imaging of neuronal activation 
 
Finally, the further development of high-speed 2P-FLIM metabolic imaging for the study of 
dynamic metabolism in the brain presents an important future direction of the work presented here. 
As was shown in Chapter 6, 2P-FLIM is unique in its ability to record both the NADH fluorescence 
transient dynamics as well as the associated lifetime dynamics, allowing specific determination of 
shifts in relative rates of key metabolic processes. This provides a major advantage over traditional 
NADH imaging approaches where analysis is difficult due to the challenges in interpreting the 
mechanisms behind the observed NADH transients. In moving forward, this imaging approach 
must be incorporated with traditional electrophysiology recording techniques such as patch 
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clamping, or single-cell recording and stimulation, in order to validate and further study the 
complex metabolic interactions observed through NADH 2P-FLIM imaging. Combination of these 
approaches and other important new developments in neuroscience such as the emerging field of 
optogenetics present the additional possibility of the development of an all-optical imaging 
platform to stimulate and record neuronal activity as well as to assess the metabolic effects of the 
local microenvironment in response to these stimuli. 
Perhaps most importantly, the mechanism behind the observed NADH transients must be further 
studied. While these dynamics have been linked to the ANLS theory, the role and extent of lactate 
metabolism in the brain is still poorly understood. While 2P-FLIM NADH imaging presents a 
sensitive approach to characterizing these NADH transients, the relationship between these 
transients, astrocytic lactate production, and neuronal metabolism of this lactate must be measured 
more directly, perhaps through the use of fluorescent probes [143]. Though this topic has remained 
controversial for decades, the development of this high-speed 2P-FLIM approach has the potential 
to provide further insight into this fundamental problem, when used in combination with the 
sensitive tools of the modern neuroscientist.  
7.3 Outlook 
The work in this thesis presents a collection of new technologies and applications for dynamic 
metabolic imaging at the cellular level. These approaches have been developed to focus here on 
the specific applications to cell death imaging and neuronal imaging due to the critical need and 
opportunity to address open questions in these fields. However, this approach has broad 
applicability to a wide range of fields that can potentially benefit from the ability to noninvasively 
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probe metabolism at fast imaging rates and with cellular-level resolution, potentially enabling the 
study of many challenging problems across the field of biomedical research.  
As cellular dynamics and energetics continue to emerge as critical biomarkers of health and 
disease, the limitation of traditional imaging approaches will become more apparent. Further 
development and application of novel imaging instruments based on these sensitive contrast 
mechanisms will provide tools capable of enabling new discoveries in the biosciences and 
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